UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 10-K

ANNUAL Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

For the fiscal year ended June 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 1-4383

ESPEY MFG. & ELECTRONICS CORP.

(Exact name of registrant as specified in its charter)

New York 14-1387171
(State of incorporation) (I.R.S. Employer's Identification No.)

233 Ballston Avenue, Saratoga Springs, New York 12866

(Address of principal executive offices)

518-584-4100

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act 

Title of each class Trading Symbol Name of each exchange on which registered
Common Stock $.33-1/3 par value ESP NYSE American

Securities registered pursuant to Section 12 (g) of the Act

None 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes     ☒ No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes     ☒ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     No

Indicate by check mark whether the registrant has submitted electronically every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes     ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company:

☐ Large accelerated filer Non-accelerated filer
☐ Accelerated filer Smaller reporting company
  Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b) ☐

Indicate by check mark whether the registrant is a shell company. ☐ Yes      No

The aggregate market value of the voting stock held by non-affiliates of the registrant was $27,145,853 based upon the closing sale price of $14.20 on the NYSE American on December 31, 2022.

At September 19, 2023 there were 2,706,633 shares outstanding of the registrant's Common stock, $.33-1/3 par value.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the registrant's definitive proxy statement relating to the 2023 Annual Meeting of Shareholders, to be filed with the Securities and Exchange Commission, are incorporated by reference in Part III, Items 10 through 14 on Form 10-K as indicated herein.

 

Forward-Looking Statements

 

This Annual Report on Form 10-K contains forward-looking statements that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors, including, without limitation:

Changing priorities or decreases in the U.S. government’s defense budget (including changes in priorities in response to terrorist threats, improvement of homeland security and general U.S. Government budgetary issues);
Termination of government contracts due to unilateral government action;
Differences in anticipated and actual program performance, including the ability to perform under long-term fixed-price contracts within estimated costs, and performance issues with key suppliers and subcontractors;
Potential of changing prices for energy and raw materials;
General strength of the industry sectors in which our customers transact business

 

All forward-looking statements speak only as of the date of this report or, in the case of any document incorporated by reference, the date of that document. All subsequent written and oral forward-looking statements attributable to the Company or any person acting on the Company’s behalf are qualified by the cautionary statements in this section. The Company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this report.

1 

 

PART I

Item 1.Business

General

Espey Mfg. & Electronics Corp. (“Espey”) is a power electronics design and original equipment manufacturing (OEM) company with a long history of developing and delivering highly reliable products for use in military and severe environment applications. Design, manufacturing, and testing is performed in our 150,000+ square foot facility located at 233 Ballston Ave., Saratoga Springs, New York. Espey is classified as a “smaller reporting company” for purposes of the reporting requirements under the Securities Exchange Act of 1934, as amended. Espey’s common stock is publicly-traded on the NYSE American under the symbol “ESP.”

Espey began operations after incorporation in New York in 1928. We strive to remain competitive as a leader in high power energy conversion and transformer solutions through the design and manufacture of new and improved products by using advanced and “cutting edge” electronics technologies.

Espey is ISO 9001:2015 and AS9100:2016 certified. Our primary products are power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, antennas and high power radar systems. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.

Espey’s services include design and development to specification, build to specifications provided by the customer “build to print”, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment. Espey is vertically integrated, meaning that the Company produces individual components (including inductors), populates printed circuit boards, fabricates metalwork, paints, wires, qualifies, and fully tests items, mechanically, electrically and environmentally, in house. Portions of the manufacturing and testing process are subcontracted to vendors from time to time.

In fiscal years ended June 30, 2023 and 2022, the Company's total sales were $35,592,323 and $32,104,774, respectively. Sales to five domestic customers accounted for 23%, 18%, 16%, 13% and 11%, respectively, of total sales in 2023. Sales to four domestic customers accounted for 17%, 16%, 14% and 11%, respectively, of total sales in 2022. This concentration level presents significant risk. A loss of one of these customers or programs related to these customers could significantly impact the financial performance of the Company. Historically, a small number of customers have accounted for a large percentage of the Company’s total sales in any given fiscal year. In some instances, our sales may include shipments to more than one business unit of a particular customer.

Export sales in fiscal years 2023 and 2022 were approximately $549,510 and $1,644,000, respectively. The decrease is primarily due to the decrease in power supply sales resulting from the timing of contractual delivery schedules.

Sources of Raw Materials

The Company has at least two potential sources of supply for a majority of its raw materials. However, certain components used in its products are available from a single or a limited number of sources. Despite the risk associated with single or limited source suppliers, the benefits of higher quality goods and timely delivery minimize and often limit any potential risk and can eliminate problems with part failures during production. At times, replacements are required to cover obsolete parts.

The growth and continuing demand in the power electronics industry across multiple manufacturing sectors, coupled with resulting supply chain disruptions from the effects of global events, has created volatility and unpredictability in the availability of certain electronic components and, in some cases, continues to create industry shortages. These shortages will likely continue to impact our ability to support our customer’s schedule demands, as lead times for these components have, in some instances, increased from readily available to waiting times of nearly a year or more. We continue to work with our customers to mitigate any adverse impact upon our ability to service their requirements. These issues, if they persist, may cause us to miss projected delivery dates.

The President of the United States continued the imposition of tariffs on steel and aluminum imports from various countries in 2022. Although we are not currently experiencing any significant financial or raw material sourcing issues resulting from the product tariffs, the Company cannot provide any assurance that the existing tariffs, the potential of additional tariffs, and the associated volatility arising from the Administration’s foreign trade policies, will not have a negative impact on our future earnings by increasing our raw material prices and augmenting the lead time for the availability of raw materials. From time to time the Company must identify parts to replace parts which are no longer produced.

2 

 

Sales Backlog

The total backlog at June 30, 2023 was approximately $83.6 million compared to approximately $76.8 million at June 30, 2022. The Company’s total backlog represents the estimated remaining sales value of work to be performed under firm contracts. The funded portion of this backlog at June 30, 2023 was approximately $83.5 million. This includes items that have been authorized and appropriated by Congress and/or funded by the customer. The unfunded backlog at June 30, 2023 was approximately $32 thousand and represents a small amount under one firm multi-year order from a single customer. While there is no guarantee that future budgets and appropriations will provide funding for individual programs, management has included in unfunded backlog only those programs that it believes are likely to receive funding based on discussions with customers and program status. The unfunded backlog at June 30, 2022 was approximately $0.4 million and represented two firm multi-year orders from a single customer for which funding had not yet been appropriated by Congress and/or funded by our customer. Contracts are subject to modification, change or cancellation, and the Company accounts for these changes as they are probable and estimable. The Company evaluates the impact of any scope modifications and will adjust reserves as information is known and estimable.

 

It is presently anticipated that a minimum of $39.5 million of orders comprising the June 30, 2023 backlog will be filled during the fiscal year ending June 30, 2024. The minimum of $39.5 million does not include any shipments which may be made against orders received subsequently to the fiscal year ending June 30, 2023. The estimate of the June 30, 2023 backlog to be shipped in fiscal year 2024 is subject to future events, which may cause the amount of the backlog actually shipped to differ from such estimate.

Marketing and Competition

The Company markets its products primarily through its own direct sales organization and through outside sales representatives. Business is solicited from large industrial manufacturers and defense companies, the government of the United States, foreign governments and major foreign electronic equipment companies. Espey is also on the eligible list of contractors with the United States Department of Defense. We pursue opportunities for prime contracts directly with the Department of Defense and are generally automatically solicited by Department of Defense procurement agencies for their needs falling within the major classes of products produced by the Company. Espey contracts with the Federal Government under cage code 20950 as Espey Mfg. & Electronics Corp.

There is competition in all classes of products manufactured by the Company ranging from divisions of the largest electronic companies, to many small companies. The Company's sales do not represent a significant share of the industry's market for any class of its products. The principal methods of competition for electronic products of both a military and industrial nature include, among other factors, price, product performance, the experience of the particular company and history of its dealings in such products.

Our business is not seasonal. However, the concentration of our business in the rail industry, and in equipment for military applications and industrial applications and our customer concentrations expose us to on-going associated risks. These risks include, without limitation, requirements for power supplies in the rail industry, dependence on appropriations from the United States Government and the governments of foreign nations, program allocations, the potential of governmental termination of orders for convenience, and the general strength of the industry sectors in which our customers transact business.

Future procurement needs supporting the military and the rail industry continue to drive competition. Many of our competitors have invested, and they continue to invest aggressively in upfront product design costs and accept lower profit margins as a strategic means of maintaining existing business and enhancing market share. This continues to put pressure on the pricing of our current products and has lowered our profit margins on some of our new business. In order to compete effectively for new business, in some cases we have invested in upfront design costs, thereby reducing initial profitability as a means of procuring new long-term programs. As part of our strategy, we adjust our pricing in order to achieve a balance which enables us both to retain repeat programs while being more competitive in bidding on new programs.

 

Our sales strategy includes identifying and obtaining multiple new engineering design and development contracts in any given fiscal year to ensure optimal utilization of our engineering personnel in addition to securing follow-on production awards for product previously designed in-house, as well as, build to print opportunities. The Company targets those programs and opportunities which will generate future longer-term production tails in ensuing years. From time to time, we accept work associated with engineering design studies. While unlikely to result in near-term follow-on orders, this positions us competitively on future awards and expands our engineering team’s skillset.

 

3 

 

Research and Development

 

Some of the Company's engineers and technicians spend varying amounts of time on either the development of new products or improvements to existing products. A majority of the resulting costs we incur relate to research that is required to support a request for quotation from a customer product-specific need usually associated with stringent size and weight requirements. We do very little pure research as our business primarily is driven by customer product needs and custom product development with some customer funding. The Company's expenditures for research and development were approximately $65,427 and $32,362 in fiscal year 2023 and 2022, respectively.

Employees

The Company had 153 employees as of August 31, 2023. Approximately 35% of the employees are represented by the International Brotherhood of Electrical Workers. The current collective bargaining agreement expires on June 30, 2025. Relations with the Union are considered good.

Government Regulations

Compliance with federal, state and local laws regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, did not in fiscal year 2023, and the Company believes will not in fiscal year 2024, have a material effect upon the capital expenditures, net income, or competitive position of the Company.

The Company’s U.S. Government contract and subcontract orders are funded by government budgets, which operate on an October-to-September fiscal year. Normally, in February of each year, the President of the United States presents to Congress a proposed budget for the upcoming fiscal year. This budget includes recommended appropriations for every federal agency and is the result of months of policy and program reviews throughout the executive branch. From February through September of each year, the appropriations and authorization committees of Congress review the President’s budget proposals and establish the funding levels for the upcoming fiscal year in appropriations and authorization legislation. Once these levels are enacted into law, the Executive Office of the President administers the funds to the agencies.

There are two primary risks associated with this process. First, the process may be delayed or disrupted because of congressional schedules, negotiations over funding levels for programs or unforeseen world events, which could, in turn, alter the funding for a program or contract. Second, funding for multi-year contracts can be changed by future appropriations, which could affect the timing of funds, schedules and program content.

Also, our international sales are denominated in United States dollars. Consequently, a strengthening of the United States dollar against foreign currencies could increase the price in local currencies of our products in foreign markets and make our products relatively more expensive than competitors’ products.

U.S. Government Defense Contracts and Subcontracts

Generally, U.S. Government contracts are subject to procurement laws and regulations. Some of the Company’s contracts are governed by the Federal Acquisition Regulation (FAR), which lays out uniform policies and procedures for acquiring goods and services by the U.S. Government, and agency-specific acquisition regulations that implement or supplement the FAR. For example, the Department of Defense implements the FAR through the Defense Federal Acquisition Regulation (DFAR).

 

The FAR also contains guidelines and regulations for managing a contract after award, including conditions under which contracts may be terminated, in whole or in part, at the government’s convenience or for default. If a contract is terminated for the convenience of the government, a contractor is entitled to receive payments for its allowable costs and, in general, the proportionate share of fees or earnings for the work done. If a contract is terminated for default, the government generally pays for only the work it has accepted. These regulations also subject the Company to financial audits and other reviews by the government of its costs, performance, accounting and general business practices relating to its contracts, which may result in adjustment of the Company’s contract-related costs and fees.

 

Cyber or Other Security Threats or Other Disruptions

 

We routinely experience cybersecurity threats in the form of unauthorized attempts to gain access to our sensitive information. The threats we face vary from attacks common to most industries to more advanced attacks with the specific objective of accessing national security information. We believe our threat detection and mitigation processes and procedures are above adequate. The processes and procedures in place are designed to detect, manage and prevent current threats and respond quickly to detect and mitigate new threats. To ensure our systems remain protected, we continually assess and acquire, as appropriate, new available technology and provide employee training to utilize effectively our technological assets. Prior cyberattacks directed at us have not had a material impact on our financial results nor restricted us from being awarded contracts from other defense companies or directly from the United States Department of Defense. However, we can provide no assurance that the occurrence of any future event would not adversely affect our internal operations, our reputation and competitive advantage, and our future financial results.

 

4 

 

Item 2.Property

The Company's entire operation, including administrative, manufacturing and engineering facilities, is located in Saratoga Springs, New York.

The Saratoga Springs plant, which the Company owns, consists of various adjoining buildings on a 22 acre site, approximately eight acres of which is unimproved. The property is not subject to mortgage indebtedness or any other material encumbrance. The plant has a sprinkler system throughout and contains approximately 151,000 square feet of floor space, of which 90,000 is used for manufacturing, 24,000 for engineering, 33,000 for shipping and climatically secured storage, and 4,000 for offices. The offices, engineering and some manufacturing areas are air-conditioned. In addition to assembly and wiring operations, the plant includes facilities for varnishing, potting, impregnation and spray-painting operations. The manufacturing operation also includes a complete machine shop, with welding and sheet metal fabrication facilities adequate for substantially all of the Company's current operations. Besides normal test equipment, the Company maintains a sophisticated on-site environmental test facility. In addition to meeting all of the Company's in-house needs, the machine shop and environmental facilities are available to other companies on a contract basis.

 

Item 3.Legal Proceedings

We are party to various litigation matters and claims arising from time to time in the ordinary course of business.  While the results of such matters cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows.  Currently, there are no matters pending.

 

Item 4.Mine Safety Disclosures

Not applicable

5 

 

PART II

Item 5.Market for the Registrant's Common Equity and Related Stockholder Matters and Issuer Purchases of Equity Securities

Price Range of Common Stock

The table below shows the range of high and low prices for the Company's common stock on the NYSE American (symbol "ESP"), the principal market for trading in the common stock, for each quarterly period for the last two fiscal years ended June 30:

2023  High   Low 
First Quarter  $15.54   $13.05 
Second Quarter   14.49    13.02 
Third Quarter   20.59    14.17 
Fourth Quarter   22.96    15.81 

 

2022  High   Low 
First Quarter  $15.40   $13.72 
Second Quarter   16.57    12.76 
Third Quarter   14.34    12.92 
Fourth Quarter   15.79    12.39 

 

Holders

The approximate number of holders of record of the common stock was 58 on September 18, 2023 according to records of the Company's transfer agent. Included in this number are shares held in "nominee" or "street" name and, therefore, the number of beneficial owners of the common stock is believed to be substantially in excess of the foregoing number.

Dividends

Effective March 13, 2023, the Company reinstated payment of a quarterly dividend. The Company had suspended dividend payments effective March 9, 2021. The Company paid regular cash dividends on common stock of $0.20 per share for the fiscal year ended June 30, 2023 and paid no cash dividends for the fiscal year ended June 30, 2022. Our Board of Directors assesses the Company’s dividend policy periodically. There is no assurance that the Board of Directors will maintain the amount of the regular cash dividend during any future years.

During fiscal year 2023, the Company did not sell any of its common stock to the Trustees of The Espey Mfg. & Electronics Corp. Employee Stock Ownership Plan Trust (the “ESOP”).

The Company did not make any open market purchases of equity securities in the fiscal year 2023 fourth quarter.

The following table sets forth information as of June 30, 2023 with respect to compensation plans under which equity securities of the Company may be issued.

Equity Compensation Plan Information

 

   Number of securities to  Weighted-average  Number of Securities remaining
   be issued upon exercise  exercise price of  available for future issuance under
   of outstanding options,  outstanding options,  equity compensation plan (excluding
Plan Category  warrants and rights  warrants and rights  securities reflected in column (a))
   (a)  (b)  (c)
Equity compensation plans approved by security holders   296,331   $19.15    154,169 
Equity compensation plans not approved by security holders             
Total   296,331         154,169 

 

6 

 

Item 7.Management's Discussion and Analysis of Financial Condition and Results of Operations

Business Outlook

Management expects revenues in fiscal year 2024 to be higher than revenues during fiscal year 2023 and expects net income per share to be higher in fiscal 2024 as compared to the net income per share realized during fiscal year 2023.

 

We successfully navigated through many of the issues which constrained our ability to recognize revenue in fiscal 2023 related to select engineering design contracts and build to print contracts which relied upon customer-owned designs to execute. While supply chain disruptions, including extended lead times and part obsolescence, continue to affect our production, we are better able to manage these factors and adequately factor lead times into internal planning schedules and new customer quotations. Inflationary costs are expected to continue but are not expected to have a significant impact on operating income in fiscal year 2024. Successful conversion of engineering program backlog into sales is largely dependent on the execution and completion of our engineering design efforts. It is not uncommon to experience technical or scheduling delays which arise from time to time as a result of, among other reasons, design complexity, the availability of personnel with the requisite expertise, and the requirements to obtain customer approval at various milestones.  Cost overruns which may arise from technical and schedule delays and increased raw material costs could negatively impact the timing of the conversion of backlog into sales, or the profitability of such sales. Engineering programs in both the funded and unfunded portions of the current backlog aggregate $8.4 million.

 

We made significant improvement in filling many of our open positions in the second half of the year. The labor workforce remains stable. Management continues to closely monitor workforce labor requirements to support our sales backlog and planned delivery schedules. Longer time-to-hire challenges remain for certain positions due to specific skillsets required for those positions and the fact fewer workers, in general, are seeking employment. Unemployment rates in the local geographic region are lower than the national average. Where possible, the Company continues to offer on-the-job training and when necessary continues to recruit personnel outside the local region. Combined with supply chain constraints, future unforeseen labor disruptions could delay shipments and result in missing our backlog fulfillment projections and recognizing lower operating income.

 

The Company currently expects new orders in fiscal 2024 to be greater than those received in fiscal year 2023. As market factors including competition and product costs impact gross profit margins, management will continue to evaluate our sales strategy, employment levels, and facility costs.

 

During fiscal year 2023, the Company received approximately $42.4 million in new orders. Our total backlog at June 30, 2023 was approximately $83.6 million, as compared to approximately $76.8 million at June 30, 2022. Currently, we expect a minimum of $39.5 million of orders comprising the June 30, 2023 backlog will be filled during the fiscal year ending June 30, 2024. This $39.5 million will be supplemented by shipments which may be made against orders received during the 2024 fiscal year. In addition to the backlog, the Company currently has outstanding opportunities representing in excess of $69 million in the aggregate as of August 31, 2023, for both repeat and new programs. The outstanding quotations encompass various new and previously manufactured power supplies, transformers, and subassemblies. However, there can be no assurance that the Company will acquire any of the anticipated orders described above, many of which are subject to allocations of the United States defense spending and factors affecting the defense industry.

 

Our sales strategy includes identifying and obtaining multiple new engineering design and development contracts in any given fiscal year to ensure optimal utilization of our engineering personnel in addition to securing follow-on production awards for product previously designed in-house, as well as, build to print opportunities. The Company targets those programs and opportunities which will generate future longer-term production tails in ensuing years. From time to time, we accept work associated with engineering design studies. While unlikely to result in near-term follow-on orders, this positions us competitively on future awards and expands our engineering team's skillset.

 

Management continues to pursue opportunities with current and new customers with an overall objective of lowering the concentration of sales, mitigating excessive reliance upon a single major product of a particular program and minimizing the impact of the loss of a single significant customer. Given the nature of our business, we believe our existing sales order backlog is fairly diversified in terms of customers and the category of products on order.

7 

 

Management, along with the Board of Directors, continues to evaluate the need and use of the Company’s working capital. Capital expenditures, primarily for machinery and equipment and facility upgrades are not expected to exceed $300,000 for fiscal year 2024. A majority of these expenditures will be made to stay competitive in the marketplace and to meet the needs of current contracts. In addition, the Company is expected to spend an amount, not to exceed $7.1 million, towards a facility and capital equipment upgrade under an award issued to us by the United States Navy.  Incurred spending is reimbursable through a milestone plan. The Company is expected to have an initial cash outlay to satisfy income tax obligations arising from the value of the award. Expectations are that the working capital will be required to fund orders, general operations of the business and dividend payments when applicable. Management along with the Legal Affairs, Strategic Planning, and M&A Committee of the Board of Directors will examine opportunities involving acquisitions or other strategic options, including buying certain products or product lines, provided that such opportunities demonstrate synergies with the Company’s existing product base and accretion to earnings.

 

Results of Operations

 

Net sales for the years ended June 30, 2023 and 2022 were $35,592,323 and $32,104,774, respectively, an approximate 10.9% increase. In general, sales fluctuations within product categories will occur during a comparable fiscal period as the direct result of product mix, influenced by the duration of specific programs and the contractual terms of firm orders placed for product and services under those programs including contract value, scope of work and duration. Deliverables within firm contracts are often subject to delivery schedules which also contributes to sales fluctuations between comparable periods. The increase in net sales in fiscal year 2023 is primarily due to an increase in shipments on contracts related to a family of power distribution transformers for a single customer when compared to sales recognized in the prior year. Sales in the current year increased on multiple new and repeat contracts which had no or significantly fewer comparable sales in the same period last year, primarily related to build to print contracts and, to a lesser extent, magnetic and power supply deliverables. In addition, sales increased in the current year from a large production contract for a power supply previously designed by the Company which had no comparable sales in the prior period and from greater sales on a large engineering design and production contract which had significantly fewer sales in the prior year. These increases were offset, in part, by decreases in sales, between the comparable periods, due to contract completion, timing of contractual delivery schedules and certain programs impeded by longer material lead times.

 

Gross profits for the twelve months ended June 30, 2023 and 2022 were $8,050,538 and $5,472,158, respectively. Gross profit as a percentage of sales was 22.6% and 17.0%, for the same periods, respectively. The primary factors in determining the change in gross profit and net income are overall sales levels and product mix. The gross profits on mature products and build to print contracts are typically higher as compared to products which are still in the engineering development stage or in early stages of production. In the case of the latter, the Company can incur what it refers to as “loss contracts,” primarily on engineering design contracts in which the Company invests with the objective of developing future product sales. In any given accounting period, the mix of product shipments between higher margin programs and less mature programs, and expenditures associated with loss contracts, has a significant impact on gross profit and net income.

 

The improvement in gross profit for the twelve months ended June 30, 2023 when compared to the same period last year resulted from an increase in sales and a higher overall gross profit percentage comprising those shipments which was influenced by product mix. In the current period, gross profit was favorably impacted from higher sales and improved margins on a specific magnetics contract and certain build to print contracts, resulting from manufacturing improvements. The current period gross profit was negatively impacted by significant costs incurred on a certain fixed-priced engineering design contract for a power supply due to the ongoing unforeseen complexity of the design and the identification of additional costs due to the unavailability of mil-spec rated parts in the marketplace resulting from part obsolescence or exceptionally long lead times. The prior year gross profit was negatively impacted by certain programs which had higher sales in the prior year and contributed less to gross profit as the result of cost overruns when compared to the same period this year.  These cost overruns included labor from both production and engineering efforts made and the impact of inflationary pricing on materials for certain fixed-price contracts.  In addition, to a lesser extent, specific to the prior year, gross profit was negatively impacted by the expensing of remaining development costs formerly capitalized in inventory on a specific engineering design program in which our customer had delayed unit qualification testing and for which production units were not expected to be manufactured in the near term.

 

Selling, general and administrative expenses were $3,750,524 for the fiscal year ended June 30, 2023; a decrease of $192,467 compared to the fiscal year ended June 30, 2022. Lower costs were incurred for the twelve months ended June 30, 2023, comparably, as the prior year spending included specific non-recurring costs attributed to a change in senior management. In addition, fewer costs were incurred in the current period when compared to the prior period resulting from a decrease in board of directors fees due to a reduction of two non-employee directors and lower professional recruiting costs incurred. The decreases in the current period were offset, in part, by increases in conference and training expenditures incurred.

 

Other income for the fiscal year ended June 30, 2023 and 2022 was $406,453 and $63,914, respectively. The increase is primarily due to the increase in interest income resulting from an increase in investment securities and an increase in fixed interest rates. Interest income is a function of the level of investments and investment strategies that generally tend to be conservative.

 

8 

 

The Company’s effective tax rate was approximately 21.9% in the fiscal year 2023 and approximately 20.6% in fiscal year 2022. The effective tax rate in fiscal 2023 is greater than the statutory tax rate mainly due to the permanent difference for incentive stock option expense recorded for book purposes which is not deductible for tax purposes. In the current year, there was no benefit received from ESOP dividends paid on allocated shares due to the suspension of the company dividend in place through February 2023. The effective tax rate in fiscal 2022 was less than the statutory tax rate mainly from the benefit derived from the ESOP dividends paid on allocated shares prior to the dividend suspension. The effective tax rate in the twelve month period ended June 30, 2023 was higher than the prior year as the direct result of a higher income before taxes in the current fiscal year offset, in part, by a decreased benefit derived from ESOP dividends paid on allocated shares.

 

The Company generated net income for fiscal year 2023 of $3,677,131 or $1.50 and $1.49 per share, basic and diluted, compared to net income of $1,265,127 or $0.52 per share, basic and diluted, for fiscal year 2022. The increase in net income in the twelve months ended June 30, 2023 compared to the same period in 2022 is primarily attributable to higher sales, a higher gross profit margin percentage, an increase in other income, and a decrease in selling, general, and administrative expenses, offset in part, by an increase in tax expense, all discussed above.

 

Liquidity and Capital Resources

The Company's working capital is an appropriate indicator of the liquidity of its business, and during the past two fiscal years, the Company, when possible, has funded all of its operations with cash flows resulting from operating activities and when necessary from its existing cash and investments. The Company did not borrow any funds during the last two fiscal years. Management has available a $3,000,000 line of credit to help fund further growth or working capital needs, if necessary, but does not anticipate the need for any borrowed funds in the foreseeable future. Contingent liabilities on outstanding standby letters of credit agreements aggregated to zero at June 30, 2023 and 2022. The existing line of credit was extended and expires February 28, 2024.

The Company's working capital as of June 30, 2023 and 2022 was approximately $33.2 million and $29.5 million, respectively. The Company may at times be required to repurchase shares at the ESOP participants’ request at the fair market value. During the twelve months ended June 30, 2023 and 2022, the Company did not repurchase any shares held by the ESOP. Under existing authorizations from the Company's Board of Directors, as of June 30, 2023, management is authorized to purchase an additional $783,460 of Company stock.

The table below presents the summary of cash flow information for the fiscal years indicated:

   2023   2022 
Net cash provided by operating activities  $3,899,870   $2,219,687 
Net cash used in investing activities   (8,765,907)   (918,339)
Net cash used in financing activities   (489,268)    

Net cash provided by operating activities fluctuates between periods primarily as a result of differences in sales and net income, provision for income taxes, the timing of the collection of accounts receivable, purchase of inventory, and payment of accounts payable. The increase in cash provided by operating activities compared to the prior year primarily relates to the increase in net income and an increase in cash collected from customer advances, offset, in part, by an increase in prepaid expenses and other current assets, an increase in inventories, and a decrease in other accrued expenses. Net cash used in investing activities increased in the twelve months ended June 30, 2023 as compared to the same period in 2022 primarily due to an increase in investment securities. Cash used in financing activities for the twelve months ended June 30, 2023 relates to dividend payments on common stock.

The Company currently believes that the cash flow generated from operations and when necessary, from cash and cash equivalents, will be sufficient to meet its long-term funding requirements for the foreseeable future.

 

During the fiscal years ended June 30, 2023 and 2022, the Company expended $512,016 and $303,561, respectively, for plant improvements and new equipment. The Company has budgeted approximately $300,000 for new equipment and plant improvements in fiscal year 2024. Management anticipates that the funds required will be available from current operations. A majority of these expenditures will be made to stay competitive in the marketplace and to meet the needs of current contracts. In addition, the Company is expected to spend an amount, not to exceed $7.1 million, towards a facility and capital equipment upgrade under an award issued to us by the United States Navy. Incurred spending is reimbursable through a milestone plan.

 

Management believes that the Company's reserve for bad debts of $3,000 is adequate given the customers with whom the Company does business. Historically, bad debt expense has been minimal.

 

9 

 

Item 8.Financial Statements and Supplementary Data

 

Report of Independent Registered Public Accounting Firm (PCAOB ID 317)

 

Financial Statements

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

To the Stockholders and Board of Directors of

Espey Mfg. & Electronics Corp.

 

Opinion on the Financial Statements

We have audited the accompanying balance sheets of Espey Mfg. & Electronics Corp. (the Company) as of June 30, 2023 and 2022, the related statements of comprehensive income, changes in stockholders’ equity and cash flows for the years then ended, and the related notes to the financial statements (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2023 and 2022, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Valuation of Inventory Costs Related to Contracts in Process and Work in Process

As discussed in Notes 2 and 5 to the financial statements, inventory relating to contracts in process and work in process is valued at cost, including factory overhead incurred to date. Contract costs include material, subcontract costs, labor, and an allocation of overhead costs. The costs attributed to units delivered under contracts are based on the estimated average cost of all units expected to be produced. Certain contracts are expected to extend beyond twelve months.

 

The estimation of total cost at completion of a contract is subject to variables involving contract costs and estimates as to the length of time to complete the contract. Given the significance of the estimation processes and judgments described above, it is possible that materially different amounts of expected sales and contract costs could be recorded if different assumptions were used, based on changes in circumstances, in the estimation process. When a change in expected sales value or estimated cost is determined, changes are reflected in current period earnings. Due to the magnitude of the inventory, and the subjectivity involved in estimating the total cost at completion we identified the evaluation of the estimate to complete as a critical audit matter, which required a high degree of auditor judgment.

 

10 

 

Addressing the matter involved performing subjective procedures and evaluating audit evidence in connection with forming our overall opinion on the financial statements. The primary procedures performed included the following:

 

We obtained an understanding of the process and assumptions used by management to develop estimates to complete including labor, overhead and materials.
We tested total cost at completion of a contract by using process employed by management, including:
oTesting the completeness and accuracy of the source information used;
oTesting the mathematical accuracy of management’s calculations;
oReviewing expected gross margin on contracts;
oEvaluating the reasonableness and consistency of methodology and assumptions applied by management; and
oPerforming a retrospective review of the prior-year estimates used to identify potential bias of management judgements.

 

 

/s/ Freed Maxick CPAs, P.C.

 

We have served as the Company's auditor since 2014.

 

Buffalo, New York

September 21, 2023

 

11 

 

Espey Mfg. & Electronics Corp.

Balance Sheets

June 30, 2023 and 2022

 

   2023   2022 
ASSETS        
Cash and cash equivalents  $2,748,755   $8,104,060 
Investment securities   11,964,673    3,708,779 
Trade accounts receivable, net of allowance of $3,000   5,755,282    5,733,174 
Income tax receivable   35,666    
 
           
Inventories:          
Raw materials   1,889,702    2,037,483 
Work-in-process   681,300    315,547 
Costs related to contracts in process   17,318,579    16,207,419 
Total inventories   19,889,581    18,560,449 
           
Prepaid expenses and other current assets   4,282,477    992,774 
Total current assets   44,676,434    37,099,236 
           
Property, plant and equipment, net   2,825,089    2,797,993 
Total assets  $47,501,523   $39,897,229 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Accounts payable  $1,212,375   $2,079,177 
Accrued expenses:          
Salaries and wages   890,748    627,187 
Vacation   685,188    666,380 
Other   547,747    752,554 
Payroll and other taxes withheld   66,042    55,292 
Contract liabilities   8,081,838    3,384,474 
Income taxes payable   
    54,722 
Total current liabilities   11,483,938    7,619,786 
           
Deferred tax liabilities   137,827    177,829 
Total liabilities   11,621,765    7,797,615 
           
Commitments and Contingencies (See Note 14)   
 
    
 
 
           
Common stock, par value $.33-1/3 per share          
Authorized 10,000,000 shares; Issued 3,129,874 shares as of June 30, 2023 and 2022. Outstanding 2,702,633 as of June 30, 2023 and 2022 (includes 233,645 and 256,293 Unearned ESOP Shares, respectively)   1,043,291    1,043,291 
Capital in excess of par value   23,283,245    23,104,693 
Accumulated other comprehensive loss   (2,429)   (1,932)
Retained  earnings   21,867,720    18,679,857 
    46,191,827    42,825,909 
           
Less:    Unearned ESOP shares   (4,273,378)   (4,687,604)
Cost of 427,241 shares of common stock in treasury as of June 30, 2023 and 2022   (6,038,691)   (6,038,691)
Total stockholders' equity   35,879,758    32,099,614 
           
Total liabilities and stockholders' equity  $47,501,523   $39,897,229 

 

The accompanying notes are an integral part of the financial statements.

12 

 

Espey Mfg. & Electronics Corp.

Statements of Comprehensive Income

Years Ended June 30, 2023 and 2022

 

   2023   2022 
         
Net sales  $35,592,323   $32,104,774 
Cost of sales   27,541,785    26,632,616 
Gross profit   8,050,538    5,472,158 
           
Selling, general and administrative expenses   3,750,524    3,942,991 
Operating income   4,300,014    1,529,167 
           
Other income          
Interest income   359,617    12,153 
Other   46,836    51,761 
Total other income   406,453    63,914 
           
Income before provision for income taxes   4,706,467    1,593,081 
           
Provision for income taxes   1,029,336    327,954 
           
Net income  $3,677,131   $1,265,127 
           
Other comprehensive income (loss), net of tax:          
Unrealized (loss) gain on investment securities   (497)   429 
           
Total comprehensive income  $3,676,634   $1,265,556 
           
Net income per share:          
Basic  $1.50   $0.52 
Diluted  $1.49   $0.52 
           
Weighted average number of shares outstanding:          
Basic   2,454,856    2,431,904 
Diluted   2,471,016    2,431,904 

 

The accompanying notes are an integral part of the financial statements.

13 

 

Espey Mfg. & Electronics Corp.

Statements of Changes in Stockholders' Equity

Years Ended June 30, 2023 and 2022

               Accumulated                     
           Capital in   Other               Unearned   Total 
   Outstanding   Common   Excess of   Comprehensive   Retained   Treasury   Treasury   ESOP   Stockholders’ 
   Shares   Amount   Par Value   (Loss) Income   Earnings   Shares   Amount   Shares   Equity 
Balance as of June 30, 2021   2,702,633   $1,043,291   $23,026,096   $(2,361)  $17,414,730    427,241   $(6,038,691)  $(5,110,770)  $30,332,295 
Comprehensive income:                                             
Net income                       1,265,127                   1,265,127 
Other comprehensive income, net of tax of $90                  429                        429 
Total comprehensive income                                           1,265,556 
Stock-based compensation             176,696                             176,696 
Reduction of unearned ESOP shares             (98,099)                       423,166    325,067 
Balance as of June 30, 2022   2,702,633   $1,043,291   $23,104,693   $(1,932)  $18,679,857    427,241   $(6,038,691)  $(4,687,604)  $32,099,614 

 

The accompanying notes are an integral part of the financial statements.

 

14 

 

Espey Mfg. & Electronics Corp.

Statements of Changes in Stockholders' Equity

Years Ended June 30, 2023 and 2022

               Accumulated                     
           Capital in   Other               Unearned   Total 
   Outstanding   Common   Excess of   Comprehensive   Retained   Treasury   Treasury   ESOP   Stockholders’ 
   Shares   Amount   Par Value   Loss   Earnings   Shares   Amount   Shares   Equity 
Balance as of June 30, 2022   2,702,633   $1,043,291   $23,104,693   $(1,932)  $18,679,857    427,241   $(6,038,691)  $(4,687,604)  $32,099,614 
Comprehensive income:                                             
Net income                       3,677,131                   3,677,131 
Other comprehensive loss, net of tax of $104                  (497)                       (497)
Total comprehensive income                                           3,676,634 
Stock-based compensation             227,132                             227,132 
Dividends paid on common stock $0.20 per share                       (489,268)                  (489,268)
Reduction of unearned ESOP shares             (48,580)                       414,226    365,646 
Balance as of June 30, 2023   2,702,633   $1,043,291   $23,283,245   $(2,429)  $21,867,720    427,241   $(6,038,691)  $(4,273,378)  $35,879,758 

 

The accompanying notes are an integral part of the financial statements.

15 

 

Espey Mfg. & Electronics Corp.

Statements of Cash Flows

Years Ended June 30, 2023 and 2022

 

   2023   2022 
Cash Flows from Operating Activities:          
Net income  $3,677,131   $1,265,127 
Adjustments to reconcile net income to net cash provided by operating activities:          
Stock-based compensation   227,132    176,696 
Depreciation   484,920    494,635 
ESOP compensation expense   365,646    325,067 
Deferred income tax (benefit) expense   (40,002)   9,271 
Gain on disposal of property, plant and equipment   (2,500)   (119)
           
Changes in assets and liabilities:          
Increase in trade accounts receivables   (22,108)   (379,393)
(Increase) decrease in income tax receivable   (35,666)   249,602 
(Increase) decrease in inventories   (1,329,132)   231,443 
Increase in prepaid expenses and other current assets   (3,289,703)   (292,477)
Decrease in accounts payable   (866,802)   (638,996)
Increase in accrued salaries and wages   263,561    151,520 
Increase (decrease) in vacation accrual   18,808    (6,231)
(Decrease) increase in other accrued expenses   (204,807)   626,540 
Increase (decrease) in payroll and other taxes withheld   10,750    (354,589)
Increase in contract liabilities   4,697,364    306,869 
(Decrease) increase in income taxes payable   (54,722)   54,722 
Net cash provided by operating activities  $3,899,870   $2,219,687 
           
Cash Flows from Investing Activities:          
Additions to property, plant and equipment   (512,016)   (303,561)
Proceeds from sale of property, plant and equipment   2,500    2,000 
Purchase of investment securities   (15,902,014)   (4,237,778)
Proceeds from sale/maturity of investment securities   7,645,623    3,621,000 
Net cash used in investing activities   (8,765,907)   (918,339)
           
Cash Flows from Financing Activities:          
Dividends paid on common stock   (489,268)   
 
Net cash used in financing activities   (489,268)   
 
           
(Decrease) increase in cash and short term investments   (5,355,305)   1,301,348 
Cash and cash equivalents, beginning of the year   8,104,060    6,802,712 
Cash and cash equivalents, end of the year  $2,748,755   $8,104,060 
           
Supplemental Schedule of Cash Flow Information:          
Income taxes paid net of refunds  $1,159,595   $14,365 

 

The accompanying notes are an integral part of the financial statements.

16 

 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 1. Nature of Operations

Espey Mfg. & Electronics Corp. (the Company) is a manufacturer of electronic equipment used primarily in military and industrial applications. The principal markets for the Company's products are companies that provide electronic support to both military and industrial applications across the United States and at some international locations.

Note 2. Summary of Significant Accounting Policies

Revenue

 

The majority of our sales are generated from military contracts from defense companies, the Department of Defense, other agencies of the government of the United States and foreign governments, for the design and development and/or manufacture of products. Sales are also generated from industrial manufacturers for similar services. We provide our products and design and development services under fixed-price contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss.

 

We account for a contract with a customer after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collection of substantially all of the amount to which the entity will be entitled in exchange for the goods or services that will be transferred to the customer is probable. We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether two or more contracts were negotiated and executed at or near the same time, or were negotiated with an overall profit objective.

 

We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. Significant judgment is required in determining performance obligations. We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. The transaction price for each performance obligation is based on the estimated standalone selling price of the product or service underlying each performance obligation. Transaction prices on our contracts subject to the Federal Acquisition Regulations (FAR) are typically based on estimated costs plus a reasonable profit margin.

 

We recognize revenue using the output method based on the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point.

 

Inventory

 

Raw materials are valued at the lower of cost (average cost) or net realizable value. Balances for slow-moving and obsolete inventory are reviewed on a regular basis by analyzing estimated demand, inventory on hand, sales levels, market conditions, and other information and reduce inventory balances based on this analysis.

 

Inventory relating to contracts in process and work in process is valued at cost, including factory overhead incurred to date. Contract costs include material, subcontract costs, labor, and an allocation of overhead costs. Work in process represents spare units and parts and other inventory items acquired or produced to service units previously sold or to meet anticipated future orders. Provision for losses on contracts is made when the existence of such losses becomes probable and estimable.  The provision for losses on contracts is included in other accrued expenses on the Company’s balance sheet.  The costs attributed to units delivered under contracts are based on the estimated average cost of all units expected to be produced.  Certain contracts are expected to extend beyond twelve months.

The estimation of total cost at completion of a contract is subject to numerous variables involving contract costs and estimates as to the length of time to complete the contract.  Given the significance of the estimation processes and judgments described above, it is possible that materially different amounts of expected sales and contract costs could be recorded if different assumptions were used, based on changes in circumstances, in the estimation process.  When a change in expected sales value or estimated cost is determined, the change is reflected in current period earnings.

 

17 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 2. Summary of Significant Accounting Policies, Continued

Contract Liabilities

Contract liabilities include advance payments and billings in excess of revenue recognized.

 

Depreciation

Depreciation of plant and equipment is computed on a straight-line basis over the estimated useful lives of the assets. 

Estimated useful lives of depreciable assets are as follows:

Buildings and improvements 1050 years
Machinery and equipment 320 years
Furniture and fixtures 710 years

 

Income Taxes

The Company follows the provisions of Accounting Standards Codification (“ASC”) Topic 740-10, "Accounting for Income Taxes."

Under the provisions of ASC 740-10, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred taxes and liabilities of a change in tax rates is recognized in earnings in the period that includes the enactment date.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash and money market funds. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. 

Investment Securities

The Company accounts for its investments in debt securities in accordance with ASC 320-10-25, “Accounting for Certain Investments in Debt and Equity Securities.”  Investments in debt securities at June 30, 2023 consists of municipal bonds, and treasury bills, and at June 30, 2022, consisted of municipal bonds.  The Company classifies investments in debt securities as available-for-sale. Unrealized holding gains and losses, net of related tax effect, on available-for-sale debt securities are excluded from earnings and are reported as a separate component of stockholders’ equity until realized.  Realized gains and losses for debt securities classified as available-for-sale are included in earnings and are determined using the specific identification method.  Interest income is recognized when earned.  Fair values are based on quoted market prices available as of the balance sheet date, and are therefore considered a Level 1 valuation.

Certificates of deposit held for investment with an original maturity greater than three months are carried at amortized cost and reported as short-term investments on the balance sheets. The type of certificates of deposit that the Company invests in are not considered debt securities under Financial Accounting Standards Board ("FASB") Accounting Standards Codification (“ASC”) 320, Investments - Debt Securities.

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820 establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.  The standard describes three levels of inputs that may be used to measure fair value:

18 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 2. Summary of Significant Accounting Policies, Continued

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.
Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
  Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The carrying amounts of financial instruments, including cash and cash equivalents, short term investment securities, accounts receivable, accounts payable and accrued expenses, approximated fair value as of June 30, 2023 and 2022 because of the immediate or short-term maturity of these financial instruments. 

Accounts Receivable and Allowance for Doubtful Accounts

The Company extends credit to its customers in the normal course of business and collateral is generally not required for trade receivables.  Exposure to credit risk is controlled through the use of credit approvals, credit limits, and monitoring procedures.  Accounts receivable are reported net of an allowance for doubtful accounts.  The Company estimates the allowance based on its analysis of specific balances. Interest is not charged on past due balances.  Based on these factors, there was an allowance for doubtful accounts of $3,000 at June 30, 2023 and 2022.  Changes to the allowance for doubtful accounts are charged to expense and reduced by charge-offs, net of recoveries.

Per Share Amounts

ASC 260-10 “Earnings Per Share (EPS)” requires the Company to calculate net income per share based on basic and diluted net income per share, as defined. Basic EPS excludes dilution and is computed by dividing net income by the weighted average number of shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. The dilutive effect of outstanding options issued by the Company are reflected in diluted EPS using the treasury stock method. Under the treasury stock method, options will only have a dilutive effect when the average market price of common stock during the period exceeds the exercise price of the options.

 

Comprehensive Income

 

Comprehensive income consists of net income and other comprehensive income (loss).  Other comprehensive income for fiscal years ended June 30, 2023 and 2022 consists of unrealized holding gains (losses) on available-for-sale debt securities. 

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

19 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 2. Summary of Significant Accounting Policies, Continued

Recently Adopted Accounting Standards

 

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” ASU 2019-12 amends ASC 740 to simplify the accounting for income taxes by removing certain exceptions for investments, intraperiod allocations and interim calculations, and adding guidance to reduce complexity in the accounting standard under the FASB’s simplification initiative. ASU 2019-12 is effective for public entities for fiscal years beginning after December 15, 2020. Upon adoption, the amendments in ASU 2019-12 should be applied on a prospective basis to all periods presented. The Company adopted the new guidance under ASU 2019-12 in the first quarter of fiscal year 2022 and removed the exception for intraperiod allocations from its interim period tax provision calculation, accordingly. The removal of the exception for intraperiod allocations did not have a material impact on the Company.

 

Recent Accounting Pronouncements Not Yet Adopted

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for public entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Upon adoption, the amendments in ASU 2016-13 should be applied on a prospective basis to all periods presented relating to available-for-sale debt securities. For all other financial instruments the Company upon adoption will apply the amendments on a modified-retrospective approach. The Company is expected to adopt the new guidance under ASU 2016-13 in the first quarter of fiscal year 2024 and is currently evaluating the impact of the adoption on its financial statements. The adoption of this standard is not expected to have a material impact on the Company’s financial statements.

 

Impairment of Long-Lived Assets

 

Long-lived assets, including property, plant, and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  There were no impairments of long-lived assets in fiscal years 2023 and 2022.  Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and no longer depreciated.  The assets and liabilities of a disposed group classified as held for sale are presented separately in the appropriate asset and liability sections of the balance sheet, if applicable.

 

Concentrations of Risk

The market for our defense electronics products is largely dependent on the availability of new contracts from the United States and foreign governments to prime contractors to which we provide components.  Any decline in expenditures by the United States or foreign governments may have an adverse effect on our financial performance. 

Generally, U.S. Government contracts are subject to procurement laws and regulations.  Some of the Company’s contracts are governed by the Federal Acquisition Regulation (FAR), which lays out uniform policies and procedures for acquiring goods and services by the U.S. Government, and agency-specific acquisition regulations that implement or supplement the FAR.  For example, the Department of Defense implements the FAR through the Defense Federal Acquisition Regulation (DFAR).

The FAR also contains guidelines and regulations for managing a contract after award, including conditions under which contracts may be terminated, in whole or in part, at the government’s convenience or for default.  If a contract is terminated for the convenience of the government, a contractor is entitled to receive payments for its allowable costs and, in general, the proportionate share of fees or earnings for the work done.  If a contract is terminated for default, the government generally pays for only the work it has accepted.  These regulations also subject the Company to financial audits and other reviews by the government of its costs, performance, accounting and general business practices relating to its contracts, which may result in adjustment of the Company’s contract-related costs and fees.

 

20 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 3. Revenue

 

The Company follows ASC 606 “Revenue from Contracts with Customers” to determine the recognition of revenue. This standard requires entities to assess the products or services promised in contracts with customers at contract inception to determine the appropriate unit at which to record revenues.  Revenue is recognized when control of the promised products or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those products or services.

 

Significant judgment is required in determining the satisfaction of performance obligations.  Revenues from our performance obligations are satisfied over time using the output method which considers the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point.  Revenue is recognized when, or as, the customer takes control of the product or services.  The output method best depicts the transfer of control to the customer as the output method represents work completed. Control is typically transferred to the customer at the shipping point as the Company has a present right to payment, the customer has legal title to the asset, the customer has the significant risks and rewards of ownership of the asset, and in most instances the customer has accepted the asset.

 

Total revenue recognized for the twelve months ended June 30, 2023 based on units delivered totaled $27,770,365 compared to $26,931,949 for the same periods in fiscal year 2022.  Total revenue recognized for the twelve months ended June 30, 2023 based on milestones achieved totaled $7,821,958 compared to $5,172,825 for the same periods in fiscal year 2022.

 

The Company offers a standard one-year product warranty. Product warranties offered by the Company are classified as assurance-type warranties, which means, the warranty only guarantees that the good or service functions as promised. Based on this, the provided warranty is not considered to be a distinct performance obligation.  The impact of variable consideration has been considered but none identified which would result in the adjustment of the transaction price as of June 30, 2023.  Our payment terms are generally 30-60 days. 

 

Contract liabilities were $8,081,838 and $3,384,474 as of June 30, 2023 and 2022, respectively.  The increase in contract liabilities is primarily due to the advance collection of cash on specific contracts, offset in part, by revenue recognized. Revenue recognized, that was in contract liabilities in the beginning of the fiscal year, approximated $2,018,642 for the twelve months ended June 30, 2023. The Company used the practical expedient to expense incremental costs incurred to obtain a contract when the contract term is less than one year.

 

The Company’s backlog at June 30, 2023 totaling approximately $83.6 million is expected, based on expected due dates, to be recognized in the following fiscal years: 47% in 2024; 38% in 2025, 11% in 2026 and 4% thereafter.   

 

Note 4. Investment Securities

Investment securities at June 30, 2023 consist of certificates of deposit, municipal bonds and U.S. treasury bills and at June 30, 2022, consisted of certificates of deposit and municipal bonds. The Company classifies investment securities as available-for-sale which have been determined to be level 1 assets.  The cost, gross unrealized gains, gross unrealized losses and fair value debt securities by major security type at June 30, 2023 and June 30, 2022 are as follows:

 

       Gross   Gross     
   Amortized   Unrealized   Unrealized   Fair 
   Cost   Gains   Losses   Value 
June 30, 2023                
Certificates of deposit  $11,280,000   $
   $
   $11,280,000 
Municipal bonds  $260,475   $165   $(7,843)  $252,797 
U.S. Treasury Bills  $430,952   $1,225   $(301)  $431,876 
Total investment securities  $11,971,427   $1,390   $(8,144)  $11,964,673 

 

21 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 4. Investment Securities, Continued

       Gross   Gross     
   Amortized   Unrealized   Unrealized   Fair 
   Cost   Gains   Losses   Value 
June 30, 2022                
Certificates of deposit  $3,639,000   $
   $
   $3,639,000 
Municipal bonds  $72,225   $
   $(2,446)  $69,779 
Total investment securities  $3,711,225   $
   $(2,446)  $3,708,779 

 

The portfolio is diversified and highly liquid and primarily consists of investment grade fixed income instruments. At June 30, 2023, the Company did not have any investments in individual securities that have been in a continuous loss position considered to be other than temporary.

As of June 30, 2023 and June 30, 2022, the remaining contractual maturities of available-for-sale debt securities were as follows:

   Years to Maturity     
   Less than   One to     
   One Year   Five Years   Total 
June 30, 2023               
Available-for-sale  $11,711,876   $252,797   $11,964,673 
                
June 30, 2022               
Available-for-sale  $3,639,000   $69,779   $3,708,779 

 

Note 5. Contracts in Process

Contracts in process at June 30, 2023 and 2022 are as follows:

 

   2023   2022 
Unrecognized gross contract value  $83,577,153   $76,782,028 
Costs related to contracts in process  $17,318,579   $16,207,419 

 

Included in costs relating to contracts in process at June 30, 2023 and 2022 are costs relative to contracts that may not be completed within the ensuing year as contracts vary in size, scope and duration. Under the units-of-delivery method, the related sale and cost of sales will not be reflected in the statements of comprehensive income until the units under contract are shipped.

Note 6. Property, Plant and Equipment

Property, plant and equipment at June 30, 2023 and 2022 is as follows:

   2023   2022 
Land  $45,000   $45,000 
Building and improvements   4,811,179    4,450,399 
Machinery and equipment   11,402,679    11,287,648 
Furniture and fixtures   164,200    164,200 
    16,423,058    15,947,247 
Accumulated depreciation   (13,597,969)   (13,149,254)
Property, plant and equipment, net  $2,825,089   $2,797,993 

 

22 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 6. Property, Plant and Equipment, Continued

Depreciation expense was $484,920 and $494,635 for the years ended June 30, 2023 and 2022, respectively.

 

The Company was awarded $7.4 million in funding during the second quarter of fiscal year 2023 in support of facility and capital equipment upgrades for testing and qualification for the United States Navy. The funding is part of the Navy’s investment to improve and sustain the Surface Combatant Industrial Base. The work will be conducted on Espey’s property in Saratoga Springs, NY, with completion slated for 2024. The Company expects to be paid within 30 days after the submission of three milestone invoices, but will not be paid for expenses incurred in excess of the specified milestone payment limits. The Company expects to have an initial cash outlay to satisfy income tax obligations arising from the value of the award. Included in building and improvements at June 30, 2023 and 2022 was $308,001 and $58,296 respectively, for facility and capital upgrades under the funding award. As of September 19, 2023, the first milestone totaling approximately $969,000 was achieved and reimbursed. The Company expects to record the receipt of milestones payments received as a reduction from the cost of the assets.

 

Note 7. Pension Expense

 

Under terms of a negotiated union contract which expires on June 30, 2025, the Company is obligated to make contributions to a union-sponsored International Brotherhood of Electrical Workers Local 1799 defined benefit pension plan (Plan identifying number is 14-6065199) covering eligible employees. Such contributions and expenses are based upon hours worked at a specified rate and amounted to $102,612 in fiscal year 2023 and $110,378 in fiscal year 2022. These contributions represent more than five percent of the total contributions made into the Plan. For the years beginning January 1, 2023 and 2022, the Plan was in the “green zone” which means it is neither endangered nor critical status. In addition, the Company is obligated to make contributions to the National Electrical Benefit Fund (NEBF) (Plan identifying number is 53-0181657). The Plan is a defined pension benefit plan covering eligible union employees. Such contributions and expenses amounted to $72,350 in fiscal year 2023 and $73,771 in fiscal year 2022. The contribution did not and will not in the future have a material impact on the Company’s financial statements.

 

The Company sponsors a 401(k) plan for non-union workers with employee and employer matching contributions. The employer match is 10% of the employee contribution and was $53,768 and $53,836, for fiscal years 2023 and 2022, respectively.

 

Note 8. Provision for Income Taxes

 

A summary of the components of the provision for income taxes for the years ended June 30, 2023 and 2022 is as follows:

 

   2023   2022 
Current tax expense - federal  $1,059,743   $313,705 
Current tax expense - state   9,595    4,978 
Deferred tax (benefit) expense   (40,002)   9,271 
Provision for income taxes  $1,029,336   $327,954 

 

Deferred income taxes reflect the impact of "temporary differences" between the amount of assets and liabilities for financial reporting purposes and such amounts measured by tax laws and regulations. These "temporary differences" are determined in accordance with ASC 740-10.

 

23 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 8. Provision for Income Taxes, Continued

The combined U.S. federal and state effective income tax rates of 21.9% and 20.6%, for 2023 and 2022 respectively, differed from the statutory U.S. federal income tax rate for the following reasons:

 

   2023   2022 
U.S. federal statutory income tax rate   21.0%   21.0%
Increase (reduction) in rate resulting from:          
State franchise tax, net of federal income tax benefit   0.2    0.3 
ESOP cost versus Fair Market Value   (0.2)   (1.3)
Dividend on allocated ESOP shares   
    (3.1)
Stock-based compensation   1.0    4.0 
Rate Differential on Net Operating Loss Carryback   
    (0.1)
Other   (0.1)   (0.2)
Effective tax rate   21.9%   20.6%

 

For the years ended June 30, 2023 and 2022 deferred income tax (benefit) expense of ($40,002) and $9,271, respectively, results from the changes in temporary differences for each year. The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities as of June 30, 2023 and 2022 are presented as follows:

 

   2023   2022 
Deferred tax assets:          
Accrued expenses  $273,059   $204,774 
ESOP   24,407    14,237 
Stock-based compensation   36,552    33,719 
Total deferred tax assets  $334,018   $252,730 
           
Deferred tax liability:          
Property, plant and equipment - principally due to differences in depreciation methods  $337,501   $374,566 
Inventory - effect of uniform capitalization   99,215    19,276 
Prepaid expenses   35,129    36,716 
Total deferred tax liability  $471,845   $430,558 
           
Net deferred tax liability  $(137,827)  $(177,828)

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projection for future taxable income over the period in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will realize the benefits of these temporary differences without consideration of a valuation allowance.

 

As the result of the implementation of the FASB interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes – An Interpretation of FASB Statement No. 109, the Company recognized no material adjustments to unrecognized tax benefits. As of June 30, 2023 and 2022, the Company has no unrecognized tax benefits.

 

24 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 8. Provision for Income Taxes, Continued

The Company recognizes interest and penalties in general and administrative expense. As of June 30, 2023 and 2022, the Company has not recorded any provision for accrued interest and penalties.

 

The Company is subject to taxation in the United States and various state jurisdictions. The federal tax returns are subject to audit for three years from date of filing unless the return was audited within that period. In general the majority of state statutes follow similar guidelines. As such, the Company’s tax returns for tax years ending June 30, 2023, 2022, and 2021 remain open to examination by the respective taxing authorities.

 

Note 9. Significant Customers

 

A significant portion of the Company's business is the production of military and industrial electronic equipment for use by the U.S. and foreign governments and certain industrial customers. Sales to five domestic customers accounted for 81% of total sales in 2023. Sales to four domestic customers accounted for 57% of total sales in 2022. The related accounts receivable balance, as a percentage of the Company's total trade accounts receivable balance, was 81% represented by five customers at June 30, 2023 and 74% represented by four customers at June 30, 2022.

 

Export sales in fiscal years 2023 and 2022 were approximately $549,510 and $1,644,000, respectively.

 

Note 10. Employee Stock Ownership Plan

 

The Company sponsors a leveraged employee stock ownership plan (the "ESOP") that covers all nonunion employees who work 1,000 or more hours per year and are employed on June 30. The Company makes annual contributions to the ESOP equal to the ESOP's debt service less dividends on unallocated shares received by the ESOP. All dividends on unallocated shares received by the ESOP are used to pay debt service. Dividends on allocated ESOP shares are recorded as a reduction of retained earnings. As the debt is repaid, shares are released and allocated to active employees, based on the proportion of debt service paid in the year. The Company accounts for its ESOP in accordance with FASB ASC 718-40. Accordingly, the shares purchased by the ESOP are reported as Unearned ESOP Shares in the statement of financial position. As shares are released or committed-to-be-released, the Company reports compensation expense equal to the current average market price of the shares, and the shares become outstanding for earnings-per-share (EPS) computations. The ESOP borrowed from the Corporation an amount equal to the purchase price.  The loan will be repaid in fifteen (15) equal annual installments of principal commencing June 2021.  The Board of Directors has fixed the interest rate and the unpaid balance will bear interest at a fixed rate of 3.00% per annum. ESOP compensation expense was $365,646 and $325,067 for the years ended June 30, 2023 and 2022, respectively.

 

The ESOP shares as of June 30, 2023 and 2022 were as follows:

 

   2023   2022 
Allocated shares   484,958    496,091 
Unreleased shares   233,645    256,293 
Total shares held by the ESOP   718,603    752,384 
Fair value of unreleased shares  $3,913,554   $3,649,612 

 

The Company may at times be required to repurchase shares at the ESOP participants’ request at the fair market value. During the twelve months ended June 30, 2023 and 2022, the Company did not repurchase shares previously held by the ESOP.

25 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 10. Employee Stock Ownership Plan, Continued

 

The ESOP allows for eligible participants to take whole share distributions from the plan on specific dates in accordance with the provision of the plan. Share distributions from the ESOP during the twelve months ended June 30, 2023 and 2022 totaled 33,780 shares and 14,265 shares, respectively.

 

Note 11. Stock-based Compensation

 

The Company follows ASC 718 in establishing standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services, as well as transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements based on the fair value of the share-based payment. ASC 718 establishes fair value as the measurement objective in accounting for share-based payment transactions with employees, except for equity instruments held by employee share ownership plans. Included as a reduction to the cost recognized for share-based payments is an estimate for option forfeitures. It is the Company’s policy to estimate expected option forfeitures based on historical experience. Actual forfeitures are adjusted prior to the vesting date if the impact is material.

 

Total stock-based compensation expense recognized in the statements of comprehensive income for the fiscal years ended June 30, 2023 and 2022, was $227,132 and $176,696, respectively, before income taxes. The amount of this stock-based compensation expense related to non-qualified stock options (“NQSO”) for the fiscal years ended June 30, 2023 and 2022, was $21,432 and $29,287, respectively. The deferred tax benefit related to the NQSO’s as of June 30, 2023 and 2022 was approximately $4,501 and $6,150, respectively. The remaining stock option expense, in each year, related to incentive stock options (“ISO”) which are not deductible by the corporation when exercised, assuming a qualifying disposition and as such no deferred tax benefit was established related to these amounts.

 

As of June 30, 2023, there was approximately $155,154 of unrecognized compensation cost related to stock option awards that is expected to be recognized as expense over the next 2 years, of which $128,766 relates to ISO’s and $26,388 relates to NQSO’s. The total deferred tax benefit related the NQSO’s in future years will be $5,541.

 

The Company has one employee stock option plan under which options or stock awards may be granted, the 2017 Stock Option and Restricted Stock Plan (the "2017 Plan"), approved by the Company's shareholders at the Company's Annual Meeting on December 1, 2017. The Board of Directors may grant options to acquire shares of common stock to employees and non-employee directors of the Company at the fair market value of the common stock on the date of grant. The maximum aggregate number of shares of common stock subject to options or awards to non-employee directors is 133,000 and the maximum aggregate number of shares of common stock subject to options or awards granted to non-employee directors during any single fiscal year is the lesser of 13,300 and 33 1/3% of the total number of shares subject to options or awards granted in such fiscal year. The maximum number of shares subject to options or awards granted to any individual employee may not exceed 15,000 in a fiscal year. Generally, options granted have a two-year vesting period based on two years of continuous service and have a ten-year contractual life. Option grants provide for accelerated vesting if there is a change in control. Shares issued upon the exercise of options are from those held in Treasury. Options covering 400,000 shares are authorized for issuance under the 2017 Plan. As of June 30, 2023, options covering 382,104 shares have been granted, of which 245,831 are outstanding, and 136,273 shares have been cancelled. As of June 30, 2023, option covering 154,169 shares remain available for grant, after factoring the cancelled shares, which are eligible to be re-granted. While no further grants of options may be made under the Company’s 2007 Stock Option and Restricted Stock Plan, as of June 30, 2023, 50,500 options were outstanding under such plan of which all are vested and exercisable.

 

ASC 718 requires the use of a valuation model to calculate the fair value of stock-based awards. The Company has elected to use the Black-Scholes option valuation model, which incorporates various assumptions including those for volatility, expected life, and interest rates.

 

26 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 11. Stock-based Compensation, Continued

The table below outlines the weighted average assumptions that the Company used to calculate the fair value of each option award for the year ended June 30, 2023 and 2022.

 

   2023  2022
Dividend yield  0.03% 
Expected stock price volatility  27.20%  25.60%
Risk-free interest rate  2.71%  0.99%
Expected option life (in years)  5.4yrs  5.4yrs
Weighted average fair value per share of options granted during the period  $4.18  $3.74

 

Effective March 13, 2023, the Company reinstated payment of a quarterly dividend. The Company paid regular cash dividends on common stock of $0.20 per share for the fiscal year ended June 30, 2023 and paid no cash dividends for the fiscal year ended June 30, 2022. Expected stock price volatility is based on the historical volatility of the Company’s stock. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options. The expected option term (in years) represents the estimated period of time until exercise and is based on actual historical experience.

 

The following table summarizes stock option activity during the twelve months ended June 30, 2023:

 

   Employee Stock Options Plan
         Weighted   
   Number of  Weighted  Average   
   Shares  Average  Remaining  Aggregate
   Subject  Exercise  Contractual  Intrinsic
   to Option  Price  Term  Value
Balance at July 1, 2022   246,273   $20.89    6.73      
Granted   74,200   $13.81    9.12      
Exercised   
    
    
      
Forfeited or expired   (24,142)  $20.46    
      
Outstanding at June 30, 2023   296,331   $19.15    6.49   $338,243 
Vested or expected to vest at June 30, 2023   283,745   $19.40    6.38   $298,723 
Exercisable at June 30, 2023   163,731   $23.13    4.74   $0 

 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the closing sale price of the Company’s common stock as reported on the NYSE American on June 30, 2023 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders had exercised their options on June 30, 2023. This amount changes based on the fair market value of the Company’s common stock. The total intrinsic values of the options exercised during the twelve months ended June 30, 2023 and 2022 was $0.

 

27 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 11. Stock-based Compensation, Continued

The following table summarizes changes in non-vested stock options during the twelve months ended June 30, 2023:

 

       Weighted 
   Number of   Average 
   Shares   Grant Date 
   Subject   Fair Value 
   to Option   (per Option) 
Non-Vested at July 1, 2022   104,175   $2.92 
Granted   74,200    4.18 
Vested   (34,075)   1.59 
Forfeited or expired   (11,700)   2.75 
Non-Vested at June 30, 2023   132,600   $3.98 

 

Note 12. Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. The Company maintains cash and cash equivalents with various financial institutions. At times such investments may be in excess of FDIC insurance limits. As disclosed in Note 9, a significant portion of the Company's business is the production of military and industrial electronic equipment for use by the U.S. and foreign governments and certain industrial customers. The related accounts receivable balance, as a percentage of the Company's total trade accounts receivable balance, was 81% represented by five customers at June 30, 2023 and 74% represented by four customers at June 30, 2022.

 

Although the Company's exposure to credit risk associated with nonpayment of these concentrated balances is affected by the conditions or occurrences within the U.S. and foreign governments, the Company believes that its trade accounts receivable credit risk exposure is limited. The Company performs ongoing credit evaluations of its customer's financial conditions and requires collateral, such as progress payments, in certain circumstances. The Company establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

Note 13. Related Parties

 

The administration of the shares of common stock held by the ESOP Trust is subject to the Espey Mfg. & Electronics Corp. Employee Retirement Plan and Trust (ESOP) and a Trust Agreement, each effective as of July 1, 2016. The Trustees’ rights with respect to the disposition of shares are governed by the terms of the Plan and the Trust Agreement. As to shares that have been allocated to the accounts of participants in the ESOP Trust, the Plan provides that the Trustees are required to vote such shares in accordance with instructions received from the participants. As to unallocated shares and allocated shares for which voting instructions have not been received from participants, the Plan provides that the Trustees are required to vote such shares in accordance with the direction of the Board of Directors of the Company under the terms of the Plan and Trust Agreement, which is currently in the same proportion as the instructions received on the allocated shares. See Note 10 for additional information regarding the ESOP.

 

Note 14. Commitments and Contingencies

 

The Company at certain times enters into standby letters of credit agreements with financial institutions primarily relating to the guarantee of future performance on certain contracts. Contingent liabilities on outstanding standby letters of credit agreements aggregated to zero at June 30, 2023 and 2022. The Company, as a U.S. Government contractor, is subject to audits, reviews, and investigations by the U.S. Government related to its negotiation and performance of government contracts and its accounting for such contracts. Failure to comply with applicable U.S. Government standards by a contractor may result in suspension from eligibility for award of any new government contract and a guilty plea or conviction may result in debarment from eligibility for awards. The government may, in certain cases, also terminate existing contracts, recover damages, and impose other sanctions and penalties. As a result of contract audits the Company will determine a range of possible outcomes and in accordance with ASC 450 “Contingencies” the Company will accrue amounts within a range that appears to be its best estimate of a possible outcome. Adjustments are made to accruals, if any, periodically based on current information.

 

28 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 14. Commitments and Contingencies, Continued

We are party to various litigation matters and claims arising from time to time in the ordinary course of business. While the results of such matters cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows. Currently, there are no matters pending.

 

Note 15. Stockholders' Equity

 

Reservation of Shares

 

The Company has reserved common shares for future issuance as follows as of June 30, 2023:

 

Stock options outstanding   296,331 
Stock options available for issuance   154,169 
Number of common shares reserved   450,500 

 

The following table sets forth the reconciliation of the numerators and denominators of the basic and diluted earnings per share computations for continuing operations for the years ended June 30:

 

   2023   2022 
Numerator:        
Net income  $3,677,131   $1,265,127 
           
Denominator:          
           
Basic EPS:          
Common shares outstanding, beginning of period   2,702,633    2,702,633 
Common shares issued to ESOP during the period   
    
 
Unearned ESOP shares   (256,293)   (279,429)
Weighted average common shares issued during the period   
    
 
Weighted average common shares purchased during the period   
    
 
Weighted average ESOP shares earned during the period   8,516    8,700 
Denominator for basic earnings per common shares – Weighted average common shares   2,454,856    2,431,904 
Diluted EPS:          
Common shares outstanding, beginning of period   2,702,633    2,702,633 
Common shares issued to ESOP during the period   
    
 
Unearned ESOP shares   (256,293)   (279,429)
Weighted average common shares issued during the period   
    
 
Weighted average common shares purchased during the period   
    
 
Weighted average ESOP shares earned during the period   8,516    8,700 
Weighted average dilutive effect of stock options   16,160    
 
Denominator for diluted earnings per common shares – Weighted average common shares   2,471,016    2,431,904 

 

29 

Espey Mfg. & Electronics Corp.

Notes to Financial Statements

Note 15. Stockholders' Equity, Continued

Not included in this computation of earnings per share for the year ended June 30, 2023 and 2022 were options to purchase 130,656 and 246,273 shares, respectively, of the Company’s common stock. These options were excluded because their inclusion would have been anti-dilutive due to the average strike price exceeding the average market price of those shares.

 

Effective March 13, 2023, the Company reinstated payment of a quarterly dividend. The Company paid regular cash dividends on common stock of $0.20 per share for the fiscal year ended June 30, 2023 and paid no cash dividends for the fiscal year ended June 30, 2022. Our Board of Directors assesses the Company’s dividend policy periodically. There is no assurance that the Board of Directors will maintain the amount of the regular cash dividend during any future years.

 

Note 16. Line of Credit

 

At June 30, 2023, the Company has an uncommitted and unused Line of Credit with a financial institution. The agreement provides that the Company may borrow up to $3,000,000. The line provides for interest payments equal to the BSBY Daily Floating Rate plus 2 percentage points. Any borrowing under the line of credit will be collateralized by accounts receivable. All outstanding balances are payable no later than the expiration date of the agreement, unless other terms are agreed to by the lender. The existing line of credit expires February 28, 2024. The Company did not borrow any funds during the last two fiscal years.

 

Note 17. Quarterly Financial Information (Unaudited)

 

   First   Second   Third   Fourth 
2023  Quarter   Quarter   Quarter   Quarter 
Net sales  $8,635,795   $8,804,109   $9,809,616   $8,342,803 
Gross profit   1,812,142    2,260,722    1,973,429    2,004,245 
Net income   768,266    1,146,042    867,288    895,535 
Net income per share -                    
Basic   0.31    0.47    0.35    0.37 
Diluted   0.31    0.47    0.35    0.36 
                     
2022                    
Net sales  $7,545,432   $7,458,050   $8,620,049   $8,481,243 
Gross profit   1,353,098    1,206,817    1,734,880    1,177,363 
Net income   306,061    21,201    661,359    276,506 
Net income per share -                    
Basic   0.13    0.01    0.27    0.11 
Diluted   0.13    0.01    0.27    0.11 

 

30 

 

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None

Item 9A.Controls and Procedures

Evaluation of Controls and Procedures

(a) The Company's management, with the participation of the Company's chief executive officer and chief financial officer, carried out an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this Annual Report on Form 10-K. Based on such evaluation, our chief executive officer and chief financial officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report.

 

(b) There have been no changes in our internal controls over financial reporting during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

 

Management’s Report on Internal Control over Financial Reporting

 

Management of our Company is responsible for establishing and maintaining adequate internal control over financial reporting, as that term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Under the supervision and with the participation of our management, including the principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission in 2013. Based on our evaluation using the criteria set forth in Internal Control-Integrated Framework, management has concluded that our internal control over financial reporting was effective as of June 30, 2023.

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Our report was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permit us to provide only management’s report in this annual report.

 

Item 9B.Other information

None

PART III

 

The information called for by "Item 10. Directors, Executive Officers, and Corporate Governance", "Item 11. Executive Compensation", "Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters", "Item 13. Certain Relationships and Related Transactions, and Director Independence" and "Item 14. Principal Accountant Fees and Services", is hereby incorporated by reference to the Company's Proxy Statement for its Annual Meeting of Shareholders, (scheduled to be held on December 1, 2023) to be filed with the SEC pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended.

31 

 

 

PART IV

Item 15. Exhibits, Financial Statement Schedules, Signatures

 

3.1 Certificate of incorporation and all amendments thereto (incorporated by  reference to Exhibit 3.1 to Espey’s Report on Form 10 -K for the year ended June 30, 2004 and Report on Form 10-Q for the quarter ended December 31, 2004)
   
3.2 Amended and Restated By-Laws (incorporated by reference to Exhibit 3.2 to Espey’s Report on Form 8-K dated September 21, 2020)
   
4.1 Description of Capital Stock (incorporated by reference to Espey's Report on Form 8-K dated October 7, 2005)
   
10.3 2007 Stock Option and Restricted Stock Plan (incorporated by reference to Espey’s Proxy Statement dated October 23, 2007 for the November 30, 2007 Annual Meeting)
   
10.4 2017 Stock Option and Restricted Stock Plan (incorporated by reference to Espey’s Proxy Statement dated October 27, 2017 for the December 1, 2017 Annual Meeting)
   
10.13 Executive Employment Agreement with David O’Neil (incorporated by reference to Exhibit 10.13 on Espey’s Report on Form 8–K dated January 1, 2022)
   
10.14 Executive Employment Agreement with Peggy Murphy (incorporated by reference to Exhibit 10.14 on Espey’s Report on Form 10–Q dated February 14, 2022)
   
   
10.16 Employment Agreement dated January 16, 2018 with Patrick Enright, Jr. (incorporated by reference to Exhibit 10.16 on Espey’s Report on Form 8-K dated January 16, 2018
   
10.16a First Amendment to Employment Agreement dated January 16, 2018 with Patrick Enright, Jr. (incorporated by reference to Exhibit 10.16 on Espey’s Report on Form 8-K dated October 12, 2021
   
10.18 Stock Purchase Agreement dated as of December 1, 2020 between Espey Mfg. & Electronics Corp. and The Trustees of the Espey Mfg. & Electronics Corp. Employee Retirement Plan Trust (incorporated by reference to Exhibit 10.18 on Espey’s Report on Form 8-K dated December 1, 2020)
   
10.19 ESOP Loan Agreement dated as of December 1, 2020 between The Trustees of Espey Mfg. & Electronics Corp. Employee Retirement Plan Trust and Espey Mfg. & Electronics Corp. (incorporated by reference to Exhibit 10.19 on Espey’s Report on Form 8-K dated December 1, 2020)
   
10.20 Executive Employment Agreement with Katrina L. Sparano (incorporated by reference to Exhibit 10.20 on  Espey’s Report on Form 8 –K dated January 1, 2022)
   
14.1 Code of ethics (incorporated by reference to Espey’s website www.espey.com)
   
23.1 Consent of Freed Maxick CPAs, P.C. (filed herewith)
   
31.1 Certification of the Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)
   
31.2 Certification of the Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)

32 

 

   
32.1 Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)
   
32.2 Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith)

 

33 

 

S I G N A T U R E S

 

 

Pursuant to the requirements of Section 13 and 15 (d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

  ESPEY MFG. & ELECTRONICS CORP.
   
   
   
  /s/ David O’Neil
  David O’Neil
  President and Chief Executive Officer
  September 21, 2023

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. 

 

 

/s/David O’Neil   President and Chief Executive Officer
David O'Neil   September 21, 2023
     
/s/Katrina Sparano   Principal Financial Officer
Katrina Sparano   September 21, 2023
     
/s/Carl Helmetag   Chairman of the Board
Carl Helmetag   September 21, 2023
     
/s/Paul J. Corr   Director
Paul J. Corr   September 21, 2023
     
/s/Nancy Patzwahl   Director
Nancy Patzwahl   September 21, 2023
     
/s/Michael W. Wool   Director
Michael W. Wool   September 21, 2023
     

 

34 

 

false FY 0000033533 0000033533 2022-07-01 2023-06-30 0000033533 2022-12-31 0000033533 2023-09-19 0000033533 2023-06-30 0000033533 2022-06-30 0000033533 2021-07-01 2022-06-30 0000033533 us-gaap:CommonStockMember 2021-06-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0000033533 us-gaap:RetainedEarningsMember 2021-06-30 0000033533 us-gaap:TreasuryStockCommonMember 2021-06-30 0000033533 esp:UnearnedESOPSharesMember 2021-06-30 0000033533 2021-06-30 0000033533 us-gaap:RetainedEarningsMember 2021-07-01 2022-06-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2022-06-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2022-06-30 0000033533 esp:UnearnedESOPSharesMember 2021-07-01 2022-06-30 0000033533 us-gaap:CommonStockMember 2022-06-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0000033533 us-gaap:RetainedEarningsMember 2022-06-30 0000033533 us-gaap:TreasuryStockCommonMember 2022-06-30 0000033533 esp:UnearnedESOPSharesMember 2022-06-30 0000033533 us-gaap:RetainedEarningsMember 2022-07-01 2023-06-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2023-06-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2023-06-30 0000033533 esp:UnearnedESOPSharesMember 2022-07-01 2023-06-30 0000033533 us-gaap:CommonStockMember 2023-06-30 0000033533 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000033533 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000033533 us-gaap:RetainedEarningsMember 2023-06-30 0000033533 us-gaap:TreasuryStockCommonMember 2023-06-30 0000033533 esp:UnearnedESOPSharesMember 2023-06-30 0000033533 srt:MinimumMember us-gaap:BuildingAndBuildingImprovementsMember 2023-06-30 0000033533 srt:MaximumMember us-gaap:BuildingAndBuildingImprovementsMember 2023-06-30 0000033533 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2023-06-30 0000033533 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2023-06-30 0000033533 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2023-06-30 0000033533 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-06-30 0000033533 esp:UnitsDeliveredMember esp:ASC606Member 2022-07-01 2023-06-30 0000033533 esp:UnitsDeliveredMember esp:ASC606Member 2021-07-01 2022-06-30 0000033533 esp:MilestonesAchievedMember esp:ASC606Member 2022-07-01 2023-06-30 0000033533 esp:MilestonesAchievedMember esp:ASC606Member 2021-07-01 2022-06-30 0000033533 esp:ASC606Member 2023-06-30 0000033533 esp:ASC606Member 2022-06-30 0000033533 esp:ASC606Member us-gaap:OrderOrProductionBacklogMember 2023-06-30 0000033533 us-gaap:CertificatesOfDepositMember 2023-06-30 0000033533 us-gaap:MunicipalBondsMember 2023-06-30 0000033533 us-gaap:USTreasuryBillSecuritiesMember 2023-06-30 0000033533 us-gaap:CertificatesOfDepositMember 2022-06-30 0000033533 us-gaap:MunicipalBondsMember 2022-06-30 0000033533 2022-07-01 2022-12-31 0000033533 us-gaap:BuildingImprovementsMember 2023-06-30 0000033533 us-gaap:BuildingImprovementsMember 2022-06-30 0000033533 2023-09-01 2023-09-19 0000033533 us-gaap:LandMember 2023-06-30 0000033533 us-gaap:LandMember 2022-06-30 0000033533 us-gaap:MachineryAndEquipmentMember 2023-06-30 0000033533 us-gaap:MachineryAndEquipmentMember 2022-06-30 0000033533 us-gaap:FurnitureAndFixturesMember 2023-06-30 0000033533 us-gaap:FurnitureAndFixturesMember 2022-06-30 0000033533 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2022-07-01 2023-06-30 0000033533 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-07-01 2022-06-30 0000033533 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember 2022-07-01 2023-06-30 0000033533 us-gaap:AccountsReceivableMember us-gaap:GeographicConcentrationRiskMember 2021-07-01 2022-06-30 0000033533 us-gaap:SalesRevenueNetMember esp:GeographicConcentrationRisk1Member 2022-07-01 2023-06-30 0000033533 us-gaap:SalesRevenueNetMember esp:GeographicConcentrationRisk1Member 2021-07-01 2022-06-30 0000033533 esp:EmployeeStockOwnershipPlanMember 2023-06-30 0000033533 esp:EmployeeStockOwnershipPlanMember 2022-07-01 2023-06-30 0000033533 esp:EmployeeStockOwnershipPlanMember 2021-07-01 2022-06-30 0000033533 esp:NonQualifiedStockOptionsMember 2022-07-01 2023-06-30 0000033533 esp:NonQualifiedStockOptionsMember 2021-07-01 2022-06-30 0000033533 esp:IncentiveStockOptionMember 2023-06-30 0000033533 esp:NonQualifiedStockOptionsMember 2023-06-30 0000033533 srt:MaximumMember esp:NonEmployeeDirectorsMember esp:TwoThousandSeventeenPlanMember 2023-06-30 0000033533 srt:MaximumMember esp:NonEmployeeDirectorsMember esp:TwoThousandSeventeenPlanMember 2022-07-01 2023-06-30 0000033533 srt:MaximumMember esp:IndividualEmployeeMember esp:TwoThousandSeventeenPlanMember 2023-06-30 0000033533 us-gaap:EmployeeStockOptionMember esp:TwoThousandSeventeenPlanMember 2022-07-01 2023-06-30 0000033533 us-gaap:EmployeeStockOptionMember esp:TwoThousandSeventeenPlanMember 2023-06-30 0000033533 esp:IncentiveStockOptionMember esp:TwoThousandSeventeenPlanMember 2022-07-01 2023-06-30 0000033533 esp:RestrictedStockPlanMember esp:TwoThousandSevenPlanMember 2022-07-01 2023-06-30 0000033533 us-gaap:SalesRevenueNetMember us-gaap:TradeAccountsReceivableMember 2022-07-01 2023-06-30 0000033533 us-gaap:SalesRevenueNetMember us-gaap:TradeAccountsReceivableMember 2021-07-01 2022-06-30 0000033533 us-gaap:StandbyLettersOfCreditMember 2023-06-30 0000033533 us-gaap:StandbyLettersOfCreditMember 2022-06-30 0000033533 esp:LondonInterbankOfferedRatesLIBORMember 2022-07-01 2023-06-30 0000033533 esp:FirstQuarterMember 2022-07-01 2023-06-30 0000033533 esp:SecondQuarterMember 2022-07-01 2023-06-30 0000033533 esp:ThirdQuarterMember 2022-07-01 2023-06-30 0000033533 esp:FourthQuarterMember 2022-07-01 2023-06-30 0000033533 esp:FirstQuarterMember 2021-07-01 2022-06-30 0000033533 esp:SecondQuarterMember 2021-07-01 2022-06-30 0000033533 esp:ThirdQuarterMember 2021-07-01 2022-06-30 0000033533 esp:FourthQuarterMember 2021-07-01 2022-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

EXHIBIT 23.1

ESPEY MFG. & ELECTRONICS CORP.

Consent of Freed Maxick CPAs, P.C.

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

 

 

Espey Mfg. & Electronics Corp.

Saratoga Springs, New York

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-148678, and 333-221891) pertaining to the 2007 and 2017 Stock Option Plans of Espey Mfg. & Electronics Corp. of our report dated September 21, 2023, with respect to the financial statements of Espey Mfg. & Electronics Corp. included in its Annual Report (Form 10-K) for the year ended June 30, 2023, filed with the Securities and Exchange Commission.

/s/Freed Maxick CPAs, P.C.

Buffalo, New York

September 21, 2023

35 

 

Exhibit 31.1

Certification of the Chief Executive Officer

Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934,

as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

I, David O’Neil, certify that:

 

1.I have reviewed this annual report on Form 10-K of Espey Mfg. & Electronics Corp;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 21, 2023

 

  /s/David O’Neil
  David O’Neil
  President and Chief Executive Officer

 

36 

 

 

Exhibit 31.2

Certification of the Principal Financial Officer

Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934,

as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

I, Katrina Sparano, certify that:

 

1.I have reviewed this annual report on Form 10-K of Espey Mfg. & Electronics Corp;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: September 21, 2023

 

  /s/Katrina Sparano
  Katrina Sparano
  Principal Financial Officer

 

37 

 

Exhibit 32.1

Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with this annual report of Espey Mfg. & Electronics Corp. (the "Company") on Form 10-K for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, David O’Neil, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: September 21, 2023

 

 

  /s/David O’Neil
  David O’Neil
  President and Chief Executive Officer

 

38 

 

Exhibit 32.2

Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350,

as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with this annual report of Espey Mfg. & Electronics Corp. (the "Company") on Form 10-K for the period ended June 30, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Katrina Sparano, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.The information contained in this report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: September 21, 2023

 

 

  /s/Katrina Sparano
  Katrina Sparano
  Principal Financial Officer

 

39 

 

v3.23.3
Document And Entity Information - USD ($)
12 Months Ended
Jun. 30, 2023
Sep. 19, 2023
Dec. 31, 2022
Document Information Line Items      
Entity Registrant Name ESPEY MFG. & ELECTRONICS CORP.    
Trading Symbol ESP    
Document Type 10-K    
Current Fiscal Year End Date --06-30    
Entity Common Stock, Shares Outstanding   2,706,633  
Entity Public Float     $ 27,145,853
Amendment Flag false    
Entity Central Index Key 0000033533    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Jun. 30, 2023    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Document Annual Report true    
Document Transition Report false    
Entity File Number 1-4383    
Entity Incorporation, State or Country Code NY    
Entity Tax Identification Number 14-1387171    
Entity Address, Address Line One 233 Ballston Avenue    
Entity Address, City or Town Saratoga Springs    
Entity Address, State or Province NY    
Entity Address, Postal Zip Code 12866    
City Area Code 518    
Local Phone Number 584-4100    
Title of 12(b) Security Common Stock $.33-1/3 par value    
Security Exchange Name NYSE    
Entity Interactive Data Current Yes    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 317    
Auditor Name Freed Maxick CPAs, P.C.    
Auditor Location Buffalo, New York    
v3.23.3
Balance Sheets - USD ($)
Jun. 30, 2023
Jun. 30, 2022
ASSETS    
Cash and cash equivalents $ 2,748,755 $ 8,104,060
Investment securities 11,964,673 3,708,779
Trade accounts receivable, net of allowance of $3,000 5,755,282 5,733,174
Income tax receivable 35,666
Inventories:    
Raw materials 1,889,702 2,037,483
Work-in-process 681,300 315,547
Costs related to contracts in process 17,318,579 16,207,419
Total inventories 19,889,581 18,560,449
Prepaid expenses and other current assets 4,282,477 992,774
Total current assets 44,676,434 37,099,236
Property, plant and equipment, net 2,825,089 2,797,993
Total assets 47,501,523 39,897,229
LIABILITIES AND STOCKHOLDERS' EQUITY    
Accounts payable 1,212,375 2,079,177
Accrued expenses:    
Salaries and wages 890,748 627,187
Vacation 685,188 666,380
Other 547,747 752,554
Payroll and other taxes withheld 66,042 55,292
Contract liabilities 8,081,838 3,384,474
Income taxes payable 54,722
Total current liabilities 11,483,938 7,619,786
Deferred tax liabilities 137,827 177,829
Total liabilities 11,621,765 7,797,615
Commitments and Contingencies (See Note 14)
Common stock, par value $.33-1/3 per share Authorized 10,000,000 shares; Issued 3,129,874 shares as of June 30, 2023 and 2022. Outstanding 2,702,633 as of June 30, 2023 and 2022 (includes 233,645 and 256,293 Unearned ESOP Shares, respectively) 1,043,291 1,043,291
Capital in excess of par value 23,283,245 23,104,693
Accumulated other comprehensive loss (2,429) (1,932)
Retained earnings 21,867,720 18,679,857
Total stockholders equity before ESOP 46,191,827 42,825,909
Less: Unearned ESOP shares (4,273,378) (4,687,604)
Cost of 427,241 shares of common stock in treasury as of June 30, 2023 and 2022 (6,038,691) (6,038,691)
Total stockholders' equity 35,879,758 32,099,614
Total liabilities and stockholders' equity $ 47,501,523 $ 39,897,229
v3.23.3
Balance Sheets (Parentheticals) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Statement of Financial Position [Abstract]    
Trade accounts receivable, allowance (in Dollars) $ 3,000 $ 3,000
Common stock, shares authorized 10,000,000 10,000,000
Common stock, shares issued 3,129,874 3,129,874
Common stock, shares outstanding 2,702,633 2,702,633
Unearned ESOP shares 233,645 256,293
Common stock, par value (in Dollars per share) $ 0.33 $ 0.33
Treasury stock, shares 427,241 427,241
v3.23.3
Statements of Comprehensive Income - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]    
Net sales $ 35,592,323 $ 32,104,774
Cost of sales 27,541,785 26,632,616
Gross profit 8,050,538 5,472,158
Selling, general and administrative expenses 3,750,524 3,942,991
Operating income 4,300,014 1,529,167
Other income    
Interest income 359,617 12,153
Other 46,836 51,761
Total other income 406,453 63,914
Income before provision for income taxes 4,706,467 1,593,081
Provision for income taxes 1,029,336 327,954
Net income 3,677,131 1,265,127
Other comprehensive income (loss), net of tax:    
Unrealized (loss) gain on investment securities (497) 429
Total comprehensive income $ 3,676,634 $ 1,265,556
Net income per share:    
Basic (in Dollars per share) $ 1.5 $ 0.52
Diluted (in Dollars per share) $ 1.49 $ 0.52
Weighted average number of shares outstanding:    
Basic (in Shares) 2,454,856 2,431,904
Diluted (in Shares) 2,471,016 2,431,904
v3.23.3
Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Capital in Excess of Par Value
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Treasury Stock
Unearned ESOP Shares
Total
Balance at Jun. 30, 2021 $ 1,043,291 $ 23,026,096 $ (2,361) $ 17,414,730 $ (6,038,691) $ (5,110,770) $ 30,332,295
Balance (in Shares) at Jun. 30, 2021 2,702,633       427,241    
Comprehensive income:              
Net income       1,265,127     1,265,127
Other comprehensive income, net of tax     429       429
Total comprehensive income             1,265,556
Stock-based compensation   176,696         176,696
Reduction of unearned ESOP shares   (98,099)       423,166 325,067
Balance at Jun. 30, 2022 $ 1,043,291 23,104,693 (1,932) 18,679,857 $ (6,038,691) (4,687,604) $ 32,099,614
Balance (in Shares) at Jun. 30, 2022 2,702,633       427,241   2,702,633
Comprehensive income:              
Net income       3,677,131     $ 3,677,131
Other comprehensive income, net of tax     (497)       (497)
Total comprehensive income             3,676,634
Stock-based compensation   227,132         227,132
Dividends paid on common stock $0.20 per share       (489,268)     (489,268)
Reduction of unearned ESOP shares   (48,580)       414,226 365,646
Balance at Jun. 30, 2023 $ 1,043,291 $ 23,283,245 $ (2,429) $ 21,867,720 $ (6,038,691) $ (4,273,378) $ 35,879,758
Balance (in Shares) at Jun. 30, 2023 2,702,633       427,241   2,702,633
v3.23.3
Statements of Changes in Stockholders' Equity (Parentheticals) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Statement of Stockholders' Equity [Abstract]    
Other comprehensive income, net of tax $ 104 $ 90
Dividends declared per share (in Dollars per share) $ 0.2  
v3.23.3
Statements of Cash Flows - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities:    
Net income $ 3,677,131 $ 1,265,127
Adjustments to reconcile net income to net cash provided by operating activities:    
Stock-based compensation 227,132 176,696
Depreciation 484,920 494,635
ESOP compensation expense 365,646 325,067
Deferred income tax (benefit) expense (40,002) 9,271
Gain on disposal of property, plant and equipment (2,500) (119)
Changes in assets and liabilities:    
Increase in trade accounts receivables (22,108) (379,393)
(Increase) decrease in income tax receivable (35,666) 249,602
(Increase) decrease in inventories (1,329,132) 231,443
Increase in prepaid expenses and other current assets (3,289,703) (292,477)
Decrease in accounts payable (866,802) (638,996)
Increase in accrued salaries and wages 263,561 151,520
Increase (decrease) in vacation accrual 18,808 (6,231)
(Decrease) increase in other accrued expenses (204,807) 626,540
Increase (decrease) in payroll and other taxes withheld 10,750 (354,589)
Increase in contract liabilities 4,697,364 306,869
(Decrease) increase in income taxes payable (54,722) 54,722
Net cash provided by operating activities 3,899,870 2,219,687
Cash Flows from Investing Activities:    
Additions to property, plant and equipment (512,016) (303,561)
Proceeds from sale of property, plant and equipment 2,500 2,000
Purchase of investment securities (15,902,014) (4,237,778)
Proceeds from sale/maturity of investment securities 7,645,623 3,621,000
Net cash used in investing activities (8,765,907) (918,339)
Cash Flows from Financing Activities:    
Dividends paid on common stock (489,268)
Net cash used in financing activities (489,268)
(Decrease) increase in cash and short term investments (5,355,305) 1,301,348
Cash and cash equivalents, beginning of the year 8,104,060 6,802,712
Cash and cash equivalents, end of the year 2,748,755 8,104,060
Supplemental Schedule of Cash Flow Information:    
Income taxes paid net of refunds $ 1,159,595 $ 14,365
v3.23.3
Nature of Operations
12 Months Ended
Jun. 30, 2023
Nature of Operations [Abstract]  
Nature of Operations

Note 1. Nature of Operations

Espey Mfg. & Electronics Corp. (the Company) is a manufacturer of electronic equipment used primarily in military and industrial applications. The principal markets for the Company's products are companies that provide electronic support to both military and industrial applications across the United States and at some international locations.

v3.23.3
Summary of Significant Accounting Policies
12 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 2. Summary of Significant Accounting Policies

Revenue

 

The majority of our sales are generated from military contracts from defense companies, the Department of Defense, other agencies of the government of the United States and foreign governments, for the design and development and/or manufacture of products. Sales are also generated from industrial manufacturers for similar services. We provide our products and design and development services under fixed-price contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss.

 

We account for a contract with a customer after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collection of substantially all of the amount to which the entity will be entitled in exchange for the goods or services that will be transferred to the customer is probable. We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether two or more contracts were negotiated and executed at or near the same time, or were negotiated with an overall profit objective.

 

We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. Significant judgment is required in determining performance obligations. We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. The transaction price for each performance obligation is based on the estimated standalone selling price of the product or service underlying each performance obligation. Transaction prices on our contracts subject to the Federal Acquisition Regulations (FAR) are typically based on estimated costs plus a reasonable profit margin.

 

We recognize revenue using the output method based on the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point.

 

Inventory

 

Raw materials are valued at the lower of cost (average cost) or net realizable value. Balances for slow-moving and obsolete inventory are reviewed on a regular basis by analyzing estimated demand, inventory on hand, sales levels, market conditions, and other information and reduce inventory balances based on this analysis.

 

Inventory relating to contracts in process and work in process is valued at cost, including factory overhead incurred to date. Contract costs include material, subcontract costs, labor, and an allocation of overhead costs. Work in process represents spare units and parts and other inventory items acquired or produced to service units previously sold or to meet anticipated future orders. Provision for losses on contracts is made when the existence of such losses becomes probable and estimable.  The provision for losses on contracts is included in other accrued expenses on the Company’s balance sheet.  The costs attributed to units delivered under contracts are based on the estimated average cost of all units expected to be produced.  Certain contracts are expected to extend beyond twelve months.

The estimation of total cost at completion of a contract is subject to numerous variables involving contract costs and estimates as to the length of time to complete the contract.  Given the significance of the estimation processes and judgments described above, it is possible that materially different amounts of expected sales and contract costs could be recorded if different assumptions were used, based on changes in circumstances, in the estimation process.  When a change in expected sales value or estimated cost is determined, the change is reflected in current period earnings.

 

Contract Liabilities

Contract liabilities include advance payments and billings in excess of revenue recognized.

 

Depreciation

Depreciation of plant and equipment is computed on a straight-line basis over the estimated useful lives of the assets. 

Estimated useful lives of depreciable assets are as follows:

Buildings and improvements 10 – 50 years
Machinery and equipment 3 – 20 years
Furniture and fixtures 7 – 10 years

 

Income Taxes

The Company follows the provisions of Accounting Standards Codification (“ASC”) Topic 740-10, "Accounting for Income Taxes."

Under the provisions of ASC 740-10, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred taxes and liabilities of a change in tax rates is recognized in earnings in the period that includes the enactment date.

Cash and Cash Equivalents

Cash and cash equivalents consist of cash and money market funds. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. 

Investment Securities

The Company accounts for its investments in debt securities in accordance with ASC 320-10-25, “Accounting for Certain Investments in Debt and Equity Securities.”  Investments in debt securities at June 30, 2023 consists of municipal bonds, and treasury bills, and at June 30, 2022, consisted of municipal bonds.  The Company classifies investments in debt securities as available-for-sale. Unrealized holding gains and losses, net of related tax effect, on available-for-sale debt securities are excluded from earnings and are reported as a separate component of stockholders’ equity until realized.  Realized gains and losses for debt securities classified as available-for-sale are included in earnings and are determined using the specific identification method.  Interest income is recognized when earned.  Fair values are based on quoted market prices available as of the balance sheet date, and are therefore considered a Level 1 valuation.

Certificates of deposit held for investment with an original maturity greater than three months are carried at amortized cost and reported as short-term investments on the balance sheets. The type of certificates of deposit that the Company invests in are not considered debt securities under Financial Accounting Standards Board ("FASB") Accounting Standards Codification (“ASC”) 320, Investments - Debt Securities.

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820 establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.  The standard describes three levels of inputs that may be used to measure fair value:

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.
Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
  Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The carrying amounts of financial instruments, including cash and cash equivalents, short term investment securities, accounts receivable, accounts payable and accrued expenses, approximated fair value as of June 30, 2023 and 2022 because of the immediate or short-term maturity of these financial instruments. 

Accounts Receivable and Allowance for Doubtful Accounts

The Company extends credit to its customers in the normal course of business and collateral is generally not required for trade receivables.  Exposure to credit risk is controlled through the use of credit approvals, credit limits, and monitoring procedures.  Accounts receivable are reported net of an allowance for doubtful accounts.  The Company estimates the allowance based on its analysis of specific balances. Interest is not charged on past due balances.  Based on these factors, there was an allowance for doubtful accounts of $3,000 at June 30, 2023 and 2022.  Changes to the allowance for doubtful accounts are charged to expense and reduced by charge-offs, net of recoveries.

Per Share Amounts

ASC 260-10 “Earnings Per Share (EPS)” requires the Company to calculate net income per share based on basic and diluted net income per share, as defined. Basic EPS excludes dilution and is computed by dividing net income by the weighted average number of shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. The dilutive effect of outstanding options issued by the Company are reflected in diluted EPS using the treasury stock method. Under the treasury stock method, options will only have a dilutive effect when the average market price of common stock during the period exceeds the exercise price of the options.

 

Comprehensive Income

 

Comprehensive income consists of net income and other comprehensive income (loss).  Other comprehensive income for fiscal years ended June 30, 2023 and 2022 consists of unrealized holding gains (losses) on available-for-sale debt securities. 

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Recently Adopted Accounting Standards

 

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” ASU 2019-12 amends ASC 740 to simplify the accounting for income taxes by removing certain exceptions for investments, intraperiod allocations and interim calculations, and adding guidance to reduce complexity in the accounting standard under the FASB’s simplification initiative. ASU 2019-12 is effective for public entities for fiscal years beginning after December 15, 2020. Upon adoption, the amendments in ASU 2019-12 should be applied on a prospective basis to all periods presented. The Company adopted the new guidance under ASU 2019-12 in the first quarter of fiscal year 2022 and removed the exception for intraperiod allocations from its interim period tax provision calculation, accordingly. The removal of the exception for intraperiod allocations did not have a material impact on the Company.

 

Recent Accounting Pronouncements Not Yet Adopted

 

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for public entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Upon adoption, the amendments in ASU 2016-13 should be applied on a prospective basis to all periods presented relating to available-for-sale debt securities. For all other financial instruments the Company upon adoption will apply the amendments on a modified-retrospective approach. The Company is expected to adopt the new guidance under ASU 2016-13 in the first quarter of fiscal year 2024 and is currently evaluating the impact of the adoption on its financial statements. The adoption of this standard is not expected to have a material impact on the Company’s financial statements.

 

Impairment of Long-Lived Assets

 

Long-lived assets, including property, plant, and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  There were no impairments of long-lived assets in fiscal years 2023 and 2022.  Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and no longer depreciated.  The assets and liabilities of a disposed group classified as held for sale are presented separately in the appropriate asset and liability sections of the balance sheet, if applicable.

 

Concentrations of Risk

The market for our defense electronics products is largely dependent on the availability of new contracts from the United States and foreign governments to prime contractors to which we provide components.  Any decline in expenditures by the United States or foreign governments may have an adverse effect on our financial performance. 

Generally, U.S. Government contracts are subject to procurement laws and regulations.  Some of the Company’s contracts are governed by the Federal Acquisition Regulation (FAR), which lays out uniform policies and procedures for acquiring goods and services by the U.S. Government, and agency-specific acquisition regulations that implement or supplement the FAR.  For example, the Department of Defense implements the FAR through the Defense Federal Acquisition Regulation (DFAR).

The FAR also contains guidelines and regulations for managing a contract after award, including conditions under which contracts may be terminated, in whole or in part, at the government’s convenience or for default.  If a contract is terminated for the convenience of the government, a contractor is entitled to receive payments for its allowable costs and, in general, the proportionate share of fees or earnings for the work done.  If a contract is terminated for default, the government generally pays for only the work it has accepted.  These regulations also subject the Company to financial audits and other reviews by the government of its costs, performance, accounting and general business practices relating to its contracts, which may result in adjustment of the Company’s contract-related costs and fees.

v3.23.3
Revenue
12 Months Ended
Jun. 30, 2023
Revenue [Abstract]  
Revenue

Note 3. Revenue

 

The Company follows ASC 606 “Revenue from Contracts with Customers” to determine the recognition of revenue. This standard requires entities to assess the products or services promised in contracts with customers at contract inception to determine the appropriate unit at which to record revenues.  Revenue is recognized when control of the promised products or services is transferred to customers at an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those products or services.

 

Significant judgment is required in determining the satisfaction of performance obligations.  Revenues from our performance obligations are satisfied over time using the output method which considers the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point.  Revenue is recognized when, or as, the customer takes control of the product or services.  The output method best depicts the transfer of control to the customer as the output method represents work completed. Control is typically transferred to the customer at the shipping point as the Company has a present right to payment, the customer has legal title to the asset, the customer has the significant risks and rewards of ownership of the asset, and in most instances the customer has accepted the asset.

 

Total revenue recognized for the twelve months ended June 30, 2023 based on units delivered totaled $27,770,365 compared to $26,931,949 for the same periods in fiscal year 2022.  Total revenue recognized for the twelve months ended June 30, 2023 based on milestones achieved totaled $7,821,958 compared to $5,172,825 for the same periods in fiscal year 2022.

 

The Company offers a standard one-year product warranty. Product warranties offered by the Company are classified as assurance-type warranties, which means, the warranty only guarantees that the good or service functions as promised. Based on this, the provided warranty is not considered to be a distinct performance obligation.  The impact of variable consideration has been considered but none identified which would result in the adjustment of the transaction price as of June 30, 2023.  Our payment terms are generally 30-60 days. 

 

Contract liabilities were $8,081,838 and $3,384,474 as of June 30, 2023 and 2022, respectively.  The increase in contract liabilities is primarily due to the advance collection of cash on specific contracts, offset in part, by revenue recognized. Revenue recognized, that was in contract liabilities in the beginning of the fiscal year, approximated $2,018,642 for the twelve months ended June 30, 2023. The Company used the practical expedient to expense incremental costs incurred to obtain a contract when the contract term is less than one year.

 

The Company’s backlog at June 30, 2023 totaling approximately $83.6 million is expected, based on expected due dates, to be recognized in the following fiscal years: 47% in 2024; 38% in 2025, 11% in 2026 and 4% thereafter.   

v3.23.3
Investment Securities
12 Months Ended
Jun. 30, 2023
Investment Securities [Abstract]  
Investment Securities

Note 4. Investment Securities

Investment securities at June 30, 2023 consist of certificates of deposit, municipal bonds and U.S. treasury bills and at June 30, 2022, consisted of certificates of deposit and municipal bonds. The Company classifies investment securities as available-for-sale which have been determined to be level 1 assets.  The cost, gross unrealized gains, gross unrealized losses and fair value debt securities by major security type at June 30, 2023 and June 30, 2022 are as follows:

 

       Gross   Gross     
   Amortized   Unrealized   Unrealized   Fair 
   Cost   Gains   Losses   Value 
June 30, 2023                
Certificates of deposit  $11,280,000   $
   $
   $11,280,000 
Municipal bonds  $260,475   $165   $(7,843)  $252,797 
U.S. Treasury Bills  $430,952   $1,225   $(301)  $431,876 
Total investment securities  $11,971,427   $1,390   $(8,144)  $11,964,673 

 

       Gross   Gross     
   Amortized   Unrealized   Unrealized   Fair 
   Cost   Gains   Losses   Value 
June 30, 2022                
Certificates of deposit  $3,639,000   $
   $
   $3,639,000 
Municipal bonds  $72,225   $
   $(2,446)  $69,779 
Total investment securities  $3,711,225   $
   $(2,446)  $3,708,779 

 

The portfolio is diversified and highly liquid and primarily consists of investment grade fixed income instruments. At June 30, 2023, the Company did not have any investments in individual securities that have been in a continuous loss position considered to be other than temporary.

As of June 30, 2023 and June 30, 2022, the remaining contractual maturities of available-for-sale debt securities were as follows:

   Years to Maturity     
   Less than   One to     
   One Year   Five Years   Total 
June 30, 2023               
Available-for-sale  $11,711,876   $252,797   $11,964,673 
                
June 30, 2022               
Available-for-sale  $3,639,000   $69,779   $3,708,779 
v3.23.3
Contracts in Process
12 Months Ended
Jun. 30, 2023
Contracts in Process [Abstract]  
Contracts in Process

Note 5. Contracts in Process

Contracts in process at June 30, 2023 and 2022 are as follows:

 

   2023   2022 
Unrecognized gross contract value  $83,577,153   $76,782,028 
Costs related to contracts in process  $17,318,579   $16,207,419 

 

Included in costs relating to contracts in process at June 30, 2023 and 2022 are costs relative to contracts that may not be completed within the ensuing year as contracts vary in size, scope and duration. Under the units-of-delivery method, the related sale and cost of sales will not be reflected in the statements of comprehensive income until the units under contract are shipped.

v3.23.3
Property, Plant and Equipment
12 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment

Note 6. Property, Plant and Equipment

Property, plant and equipment at June 30, 2023 and 2022 is as follows:

   2023   2022 
Land  $45,000   $45,000 
Building and improvements   4,811,179    4,450,399 
Machinery and equipment   11,402,679    11,287,648 
Furniture and fixtures   164,200    164,200 
    16,423,058    15,947,247 
Accumulated depreciation   (13,597,969)   (13,149,254)
Property, plant and equipment, net  $2,825,089   $2,797,993 

 

Depreciation expense was $484,920 and $494,635 for the years ended June 30, 2023 and 2022, respectively.

 

The Company was awarded $7.4 million in funding during the second quarter of fiscal year 2023 in support of facility and capital equipment upgrades for testing and qualification for the United States Navy. The funding is part of the Navy’s investment to improve and sustain the Surface Combatant Industrial Base. The work will be conducted on Espey’s property in Saratoga Springs, NY, with completion slated for 2024. The Company expects to be paid within 30 days after the submission of three milestone invoices, but will not be paid for expenses incurred in excess of the specified milestone payment limits. The Company expects to have an initial cash outlay to satisfy income tax obligations arising from the value of the award. Included in building and improvements at June 30, 2023 and 2022 was $308,001 and $58,296 respectively, for facility and capital upgrades under the funding award. As of September 19, 2023, the first milestone totaling approximately $969,000 was achieved and reimbursed. The Company expects to record the receipt of milestones payments received as a reduction from the cost of the assets.

v3.23.3
Pension Expense
12 Months Ended
Jun. 30, 2023
Pension Expense [Abstract]  
Pension Expense

Note 7. Pension Expense

 

Under terms of a negotiated union contract which expires on June 30, 2025, the Company is obligated to make contributions to a union-sponsored International Brotherhood of Electrical Workers Local 1799 defined benefit pension plan (Plan identifying number is 14-6065199) covering eligible employees. Such contributions and expenses are based upon hours worked at a specified rate and amounted to $102,612 in fiscal year 2023 and $110,378 in fiscal year 2022. These contributions represent more than five percent of the total contributions made into the Plan. For the years beginning January 1, 2023 and 2022, the Plan was in the “green zone” which means it is neither endangered nor critical status. In addition, the Company is obligated to make contributions to the National Electrical Benefit Fund (NEBF) (Plan identifying number is 53-0181657). The Plan is a defined pension benefit plan covering eligible union employees. Such contributions and expenses amounted to $72,350 in fiscal year 2023 and $73,771 in fiscal year 2022. The contribution did not and will not in the future have a material impact on the Company’s financial statements.

 

The Company sponsors a 401(k) plan for non-union workers with employee and employer matching contributions. The employer match is 10% of the employee contribution and was $53,768 and $53,836, for fiscal years 2023 and 2022, respectively.

v3.23.3
Provision for Income Taxes
12 Months Ended
Jun. 30, 2023
Provision for Income Taxes [Abstract]  
Provision for Income Taxes

Note 8. Provision for Income Taxes

 

A summary of the components of the provision for income taxes for the years ended June 30, 2023 and 2022 is as follows:

 

   2023   2022 
Current tax expense - federal  $1,059,743   $313,705 
Current tax expense - state   9,595    4,978 
Deferred tax (benefit) expense   (40,002)   9,271 
Provision for income taxes  $1,029,336   $327,954 

 

Deferred income taxes reflect the impact of "temporary differences" between the amount of assets and liabilities for financial reporting purposes and such amounts measured by tax laws and regulations. These "temporary differences" are determined in accordance with ASC 740-10.

 

The combined U.S. federal and state effective income tax rates of 21.9% and 20.6%, for 2023 and 2022 respectively, differed from the statutory U.S. federal income tax rate for the following reasons:

 

   2023   2022 
U.S. federal statutory income tax rate   21.0%   21.0%
Increase (reduction) in rate resulting from:          
State franchise tax, net of federal income tax benefit   0.2    0.3 
ESOP cost versus Fair Market Value   (0.2)   (1.3)
Dividend on allocated ESOP shares   
    (3.1)
Stock-based compensation   1.0    4.0 
Rate Differential on Net Operating Loss Carryback   
    (0.1)
Other   (0.1)   (0.2)
Effective tax rate   21.9%   20.6%

 

For the years ended June 30, 2023 and 2022 deferred income tax (benefit) expense of ($40,002) and $9,271, respectively, results from the changes in temporary differences for each year. The tax effects of temporary differences that give rise to deferred tax assets and deferred tax liabilities as of June 30, 2023 and 2022 are presented as follows:

 

   2023   2022 
Deferred tax assets:          
Accrued expenses  $273,059   $204,774 
ESOP   24,407    14,237 
Stock-based compensation   36,552    33,719 
Total deferred tax assets  $334,018   $252,730 
           
Deferred tax liability:          
Property, plant and equipment - principally due to differences in depreciation methods  $337,501   $374,566 
Inventory - effect of uniform capitalization   99,215    19,276 
Prepaid expenses   35,129    36,716 
Total deferred tax liability  $471,845   $430,558 
           
Net deferred tax liability  $(137,827)  $(177,828)

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies in making this assessment. Based upon the level of historical taxable income and projection for future taxable income over the period in which the deferred tax assets are deductible, management believes it is more likely than not that the Company will realize the benefits of these temporary differences without consideration of a valuation allowance.

 

As the result of the implementation of the FASB interpretation No. 48 (“FIN 48”), Accounting for Uncertainty in Income Taxes – An Interpretation of FASB Statement No. 109, the Company recognized no material adjustments to unrecognized tax benefits. As of June 30, 2023 and 2022, the Company has no unrecognized tax benefits.

 

The Company recognizes interest and penalties in general and administrative expense. As of June 30, 2023 and 2022, the Company has not recorded any provision for accrued interest and penalties.

 

The Company is subject to taxation in the United States and various state jurisdictions. The federal tax returns are subject to audit for three years from date of filing unless the return was audited within that period. In general the majority of state statutes follow similar guidelines. As such, the Company’s tax returns for tax years ending June 30, 2023, 2022, and 2021 remain open to examination by the respective taxing authorities.

v3.23.3
Significant Customers
12 Months Ended
Jun. 30, 2023
Significant Customers [Abstract]  
Significant Customers

Note 9. Significant Customers

 

A significant portion of the Company's business is the production of military and industrial electronic equipment for use by the U.S. and foreign governments and certain industrial customers. Sales to five domestic customers accounted for 81% of total sales in 2023. Sales to four domestic customers accounted for 57% of total sales in 2022. The related accounts receivable balance, as a percentage of the Company's total trade accounts receivable balance, was 81% represented by five customers at June 30, 2023 and 74% represented by four customers at June 30, 2022.

 

Export sales in fiscal years 2023 and 2022 were approximately $549,510 and $1,644,000, respectively.

v3.23.3
Employee Stock Ownership Plan
12 Months Ended
Jun. 30, 2023
Employee Stock Ownership Plan [Abstract]  
Employee Stock Ownership Plan

Note 10. Employee Stock Ownership Plan

 

The Company sponsors a leveraged employee stock ownership plan (the "ESOP") that covers all nonunion employees who work 1,000 or more hours per year and are employed on June 30. The Company makes annual contributions to the ESOP equal to the ESOP's debt service less dividends on unallocated shares received by the ESOP. All dividends on unallocated shares received by the ESOP are used to pay debt service. Dividends on allocated ESOP shares are recorded as a reduction of retained earnings. As the debt is repaid, shares are released and allocated to active employees, based on the proportion of debt service paid in the year. The Company accounts for its ESOP in accordance with FASB ASC 718-40. Accordingly, the shares purchased by the ESOP are reported as Unearned ESOP Shares in the statement of financial position. As shares are released or committed-to-be-released, the Company reports compensation expense equal to the current average market price of the shares, and the shares become outstanding for earnings-per-share (EPS) computations. The ESOP borrowed from the Corporation an amount equal to the purchase price.  The loan will be repaid in fifteen (15) equal annual installments of principal commencing June 2021.  The Board of Directors has fixed the interest rate and the unpaid balance will bear interest at a fixed rate of 3.00% per annum. ESOP compensation expense was $365,646 and $325,067 for the years ended June 30, 2023 and 2022, respectively.

 

The ESOP shares as of June 30, 2023 and 2022 were as follows:

 

   2023   2022 
Allocated shares   484,958    496,091 
Unreleased shares   233,645    256,293 
Total shares held by the ESOP   718,603    752,384 
Fair value of unreleased shares  $3,913,554   $3,649,612 

 

The Company may at times be required to repurchase shares at the ESOP participants’ request at the fair market value. During the twelve months ended June 30, 2023 and 2022, the Company did not repurchase shares previously held by the ESOP.

The ESOP allows for eligible participants to take whole share distributions from the plan on specific dates in accordance with the provision of the plan. Share distributions from the ESOP during the twelve months ended June 30, 2023 and 2022 totaled 33,780 shares and 14,265 shares, respectively.

v3.23.3
Stock-Based Compensation
12 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

Note 11. Stock-based Compensation

 

The Company follows ASC 718 in establishing standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services, as well as transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments. ASC 718 requires that the cost resulting from all share-based payment transactions be recognized in the financial statements based on the fair value of the share-based payment. ASC 718 establishes fair value as the measurement objective in accounting for share-based payment transactions with employees, except for equity instruments held by employee share ownership plans. Included as a reduction to the cost recognized for share-based payments is an estimate for option forfeitures. It is the Company’s policy to estimate expected option forfeitures based on historical experience. Actual forfeitures are adjusted prior to the vesting date if the impact is material.

 

Total stock-based compensation expense recognized in the statements of comprehensive income for the fiscal years ended June 30, 2023 and 2022, was $227,132 and $176,696, respectively, before income taxes. The amount of this stock-based compensation expense related to non-qualified stock options (“NQSO”) for the fiscal years ended June 30, 2023 and 2022, was $21,432 and $29,287, respectively. The deferred tax benefit related to the NQSO’s as of June 30, 2023 and 2022 was approximately $4,501 and $6,150, respectively. The remaining stock option expense, in each year, related to incentive stock options (“ISO”) which are not deductible by the corporation when exercised, assuming a qualifying disposition and as such no deferred tax benefit was established related to these amounts.

 

As of June 30, 2023, there was approximately $155,154 of unrecognized compensation cost related to stock option awards that is expected to be recognized as expense over the next 2 years, of which $128,766 relates to ISO’s and $26,388 relates to NQSO’s. The total deferred tax benefit related the NQSO’s in future years will be $5,541.

 

The Company has one employee stock option plan under which options or stock awards may be granted, the 2017 Stock Option and Restricted Stock Plan (the "2017 Plan"), approved by the Company's shareholders at the Company's Annual Meeting on December 1, 2017. The Board of Directors may grant options to acquire shares of common stock to employees and non-employee directors of the Company at the fair market value of the common stock on the date of grant. The maximum aggregate number of shares of common stock subject to options or awards to non-employee directors is 133,000 and the maximum aggregate number of shares of common stock subject to options or awards granted to non-employee directors during any single fiscal year is the lesser of 13,300 and 33 1/3% of the total number of shares subject to options or awards granted in such fiscal year. The maximum number of shares subject to options or awards granted to any individual employee may not exceed 15,000 in a fiscal year. Generally, options granted have a two-year vesting period based on two years of continuous service and have a ten-year contractual life. Option grants provide for accelerated vesting if there is a change in control. Shares issued upon the exercise of options are from those held in Treasury. Options covering 400,000 shares are authorized for issuance under the 2017 Plan. As of June 30, 2023, options covering 382,104 shares have been granted, of which 245,831 are outstanding, and 136,273 shares have been cancelled. As of June 30, 2023, option covering 154,169 shares remain available for grant, after factoring the cancelled shares, which are eligible to be re-granted. While no further grants of options may be made under the Company’s 2007 Stock Option and Restricted Stock Plan, as of June 30, 2023, 50,500 options were outstanding under such plan of which all are vested and exercisable.

 

ASC 718 requires the use of a valuation model to calculate the fair value of stock-based awards. The Company has elected to use the Black-Scholes option valuation model, which incorporates various assumptions including those for volatility, expected life, and interest rates.

 

The table below outlines the weighted average assumptions that the Company used to calculate the fair value of each option award for the year ended June 30, 2023 and 2022.

 

   2023  2022
Dividend yield  0.03% 
Expected stock price volatility  27.20%  25.60%
Risk-free interest rate  2.71%  0.99%
Expected option life (in years)  5.4yrs  5.4yrs
Weighted average fair value per share of options granted during the period  $4.18  $3.74

 

Effective March 13, 2023, the Company reinstated payment of a quarterly dividend. The Company paid regular cash dividends on common stock of $0.20 per share for the fiscal year ended June 30, 2023 and paid no cash dividends for the fiscal year ended June 30, 2022. Expected stock price volatility is based on the historical volatility of the Company’s stock. The risk-free interest rate is based on the implied yield available on U.S. Treasury issues with an equivalent term approximating the expected life of the options. The expected option term (in years) represents the estimated period of time until exercise and is based on actual historical experience.

 

The following table summarizes stock option activity during the twelve months ended June 30, 2023:

 

   Employee Stock Options Plan
         Weighted   
   Number of  Weighted  Average   
   Shares  Average  Remaining  Aggregate
   Subject  Exercise  Contractual  Intrinsic
   to Option  Price  Term  Value
Balance at July 1, 2022   246,273   $20.89    6.73      
Granted   74,200   $13.81    9.12      
Exercised   
    
    
      
Forfeited or expired   (24,142)  $20.46    
      
Outstanding at June 30, 2023   296,331   $19.15    6.49   $338,243 
Vested or expected to vest at June 30, 2023   283,745   $19.40    6.38   $298,723 
Exercisable at June 30, 2023   163,731   $23.13    4.74   $0 

 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between the closing sale price of the Company’s common stock as reported on the NYSE American on June 30, 2023 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders if all option holders had exercised their options on June 30, 2023. This amount changes based on the fair market value of the Company’s common stock. The total intrinsic values of the options exercised during the twelve months ended June 30, 2023 and 2022 was $0.

 

The following table summarizes changes in non-vested stock options during the twelve months ended June 30, 2023:

 

       Weighted 
   Number of   Average 
   Shares   Grant Date 
   Subject   Fair Value 
   to Option   (per Option) 
Non-Vested at July 1, 2022   104,175   $2.92 
Granted   74,200    4.18 
Vested   (34,075)   1.59 
Forfeited or expired   (11,700)   2.75 
Non-Vested at June 30, 2023   132,600   $3.98 
v3.23.3
Concentration of Credit Risk
12 Months Ended
Jun. 30, 2023
Concentration of Credit Risk [Abstract]  
Concentration of Credit Risk

Note 12. Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments and accounts receivable. The Company maintains cash and cash equivalents with various financial institutions. At times such investments may be in excess of FDIC insurance limits. As disclosed in Note 9, a significant portion of the Company's business is the production of military and industrial electronic equipment for use by the U.S. and foreign governments and certain industrial customers. The related accounts receivable balance, as a percentage of the Company's total trade accounts receivable balance, was 81% represented by five customers at June 30, 2023 and 74% represented by four customers at June 30, 2022.

 

Although the Company's exposure to credit risk associated with nonpayment of these concentrated balances is affected by the conditions or occurrences within the U.S. and foreign governments, the Company believes that its trade accounts receivable credit risk exposure is limited. The Company performs ongoing credit evaluations of its customer's financial conditions and requires collateral, such as progress payments, in certain circumstances. The Company establishes an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

v3.23.3
Related Parties
12 Months Ended
Jun. 30, 2023
Related Parties [Abstract]  
Related Parties

Note 13. Related Parties

 

The administration of the shares of common stock held by the ESOP Trust is subject to the Espey Mfg. & Electronics Corp. Employee Retirement Plan and Trust (ESOP) and a Trust Agreement, each effective as of July 1, 2016. The Trustees’ rights with respect to the disposition of shares are governed by the terms of the Plan and the Trust Agreement. As to shares that have been allocated to the accounts of participants in the ESOP Trust, the Plan provides that the Trustees are required to vote such shares in accordance with instructions received from the participants. As to unallocated shares and allocated shares for which voting instructions have not been received from participants, the Plan provides that the Trustees are required to vote such shares in accordance with the direction of the Board of Directors of the Company under the terms of the Plan and Trust Agreement, which is currently in the same proportion as the instructions received on the allocated shares. See Note 10 for additional information regarding the ESOP.

v3.23.3
Commitments and Contingencies
12 Months Ended
Jun. 30, 2023
Commitments and Contingencies [Abstract]  
Commitments and Contingencies

Note 14. Commitments and Contingencies

 

The Company at certain times enters into standby letters of credit agreements with financial institutions primarily relating to the guarantee of future performance on certain contracts. Contingent liabilities on outstanding standby letters of credit agreements aggregated to zero at June 30, 2023 and 2022. The Company, as a U.S. Government contractor, is subject to audits, reviews, and investigations by the U.S. Government related to its negotiation and performance of government contracts and its accounting for such contracts. Failure to comply with applicable U.S. Government standards by a contractor may result in suspension from eligibility for award of any new government contract and a guilty plea or conviction may result in debarment from eligibility for awards. The government may, in certain cases, also terminate existing contracts, recover damages, and impose other sanctions and penalties. As a result of contract audits the Company will determine a range of possible outcomes and in accordance with ASC 450 “Contingencies” the Company will accrue amounts within a range that appears to be its best estimate of a possible outcome. Adjustments are made to accruals, if any, periodically based on current information.

 

We are party to various litigation matters and claims arising from time to time in the ordinary course of business. While the results of such matters cannot be predicted with certainty, we believe that the final outcome of such matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows. Currently, there are no matters pending.

v3.23.3
Stockholders' Equity
12 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

Note 15. Stockholders' Equity

 

Reservation of Shares

 

The Company has reserved common shares for future issuance as follows as of June 30, 2023:

 

Stock options outstanding   296,331 
Stock options available for issuance   154,169 
Number of common shares reserved   450,500 

 

The following table sets forth the reconciliation of the numerators and denominators of the basic and diluted earnings per share computations for continuing operations for the years ended June 30:

 

   2023   2022 
Numerator:        
Net income  $3,677,131   $1,265,127 
           
Denominator:          
           
Basic EPS:          
Common shares outstanding, beginning of period   2,702,633    2,702,633 
Common shares issued to ESOP during the period   
    
 
Unearned ESOP shares   (256,293)   (279,429)
Weighted average common shares issued during the period   
    
 
Weighted average common shares purchased during the period   
    
 
Weighted average ESOP shares earned during the period   8,516    8,700 
Denominator for basic earnings per common shares – Weighted average common shares   2,454,856    2,431,904 
Diluted EPS:          
Common shares outstanding, beginning of period   2,702,633    2,702,633 
Common shares issued to ESOP during the period   
    
 
Unearned ESOP shares   (256,293)   (279,429)
Weighted average common shares issued during the period   
    
 
Weighted average common shares purchased during the period   
    
 
Weighted average ESOP shares earned during the period   8,516    8,700 
Weighted average dilutive effect of stock options   16,160    
 
Denominator for diluted earnings per common shares – Weighted average common shares   2,471,016    2,431,904 

 

Not included in this computation of earnings per share for the year ended June 30, 2023 and 2022 were options to purchase 130,656 and 246,273 shares, respectively, of the Company’s common stock. These options were excluded because their inclusion would have been anti-dilutive due to the average strike price exceeding the average market price of those shares.

 

Effective March 13, 2023, the Company reinstated payment of a quarterly dividend. The Company paid regular cash dividends on common stock of $0.20 per share for the fiscal year ended June 30, 2023 and paid no cash dividends for the fiscal year ended June 30, 2022. Our Board of Directors assesses the Company’s dividend policy periodically. There is no assurance that the Board of Directors will maintain the amount of the regular cash dividend during any future years.

v3.23.3
Line of Credit
12 Months Ended
Jun. 30, 2023
Line of Credit [Abstract]  
Line of Credit

Note 16. Line of Credit

 

At June 30, 2023, the Company has an uncommitted and unused Line of Credit with a financial institution. The agreement provides that the Company may borrow up to $3,000,000. The line provides for interest payments equal to the BSBY Daily Floating Rate plus 2 percentage points. Any borrowing under the line of credit will be collateralized by accounts receivable. All outstanding balances are payable no later than the expiration date of the agreement, unless other terms are agreed to by the lender. The existing line of credit expires February 28, 2024. The Company did not borrow any funds during the last two fiscal years.

v3.23.3
Quarterly Financial Information (Unaudited)
12 Months Ended
Jun. 30, 2023
Quarterly Financial Information (Unaudited) [Abstract]  
Quarterly Financial Information (Unaudited)

Note 17. Quarterly Financial Information (Unaudited)

 

   First   Second   Third   Fourth 
2023  Quarter   Quarter   Quarter   Quarter 
Net sales  $8,635,795   $8,804,109   $9,809,616   $8,342,803 
Gross profit   1,812,142    2,260,722    1,973,429    2,004,245 
Net income   768,266    1,146,042    867,288    895,535 
Net income per share -                    
Basic   0.31    0.47    0.35    0.37 
Diluted   0.31    0.47    0.35    0.36 
                     
2022                    
Net sales  $7,545,432   $7,458,050   $8,620,049   $8,481,243 
Gross profit   1,353,098    1,206,817    1,734,880    1,177,363 
Net income   306,061    21,201    661,359    276,506 
Net income per share -                    
Basic   0.13    0.01    0.27    0.11 
Diluted   0.13    0.01    0.27    0.11 
v3.23.3
Accounting Policies, by Policy (Policies)
12 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Revenue

Revenue

The majority of our sales are generated from military contracts from defense companies, the Department of Defense, other agencies of the government of the United States and foreign governments, for the design and development and/or manufacture of products. Sales are also generated from industrial manufacturers for similar services. We provide our products and design and development services under fixed-price contracts. Under fixed-price contracts we agree to perform the specified work for a pre-determined price. To the extent our actual costs vary from the estimates upon which the price was negotiated, we will generate more or less profit or could incur a loss.

We account for a contract with a customer after it has been approved by all parties to the arrangement, the rights of the parties are identified, payment terms are identified, the contract has commercial substance, and collection of substantially all of the amount to which the entity will be entitled in exchange for the goods or services that will be transferred to the customer is probable. We assess each contract at its inception to determine whether it should be combined with other contracts. When making this determination, we consider factors such as whether two or more contracts were negotiated and executed at or near the same time, or were negotiated with an overall profit objective.

We evaluate the products or services promised in each contract at inception to determine whether the contract should be accounted for as having one or more performance obligations. Significant judgment is required in determining performance obligations. We determine the transaction price for each contract based on the consideration we expect to receive for the products or services being provided under the contract. The transaction price for each performance obligation is based on the estimated standalone selling price of the product or service underlying each performance obligation. Transaction prices on our contracts subject to the Federal Acquisition Regulations (FAR) are typically based on estimated costs plus a reasonable profit margin.

We recognize revenue using the output method based on the appraisal of results achieved and milestones reached or units delivered based on contractual shipment terms, typically shipping point.

Inventory

Inventory

Raw materials are valued at the lower of cost (average cost) or net realizable value. Balances for slow-moving and obsolete inventory are reviewed on a regular basis by analyzing estimated demand, inventory on hand, sales levels, market conditions, and other information and reduce inventory balances based on this analysis.

Inventory relating to contracts in process and work in process is valued at cost, including factory overhead incurred to date. Contract costs include material, subcontract costs, labor, and an allocation of overhead costs. Work in process represents spare units and parts and other inventory items acquired or produced to service units previously sold or to meet anticipated future orders. Provision for losses on contracts is made when the existence of such losses becomes probable and estimable.  The provision for losses on contracts is included in other accrued expenses on the Company’s balance sheet.  The costs attributed to units delivered under contracts are based on the estimated average cost of all units expected to be produced.  Certain contracts are expected to extend beyond twelve months.

The estimation of total cost at completion of a contract is subject to numerous variables involving contract costs and estimates as to the length of time to complete the contract.  Given the significance of the estimation processes and judgments described above, it is possible that materially different amounts of expected sales and contract costs could be recorded if different assumptions were used, based on changes in circumstances, in the estimation process.  When a change in expected sales value or estimated cost is determined, the change is reflected in current period earnings.

 

Contract Liabilities

Contract Liabilities

Contract liabilities include advance payments and billings in excess of revenue recognized.

Depreciation

Depreciation

Depreciation of plant and equipment is computed on a straight-line basis over the estimated useful lives of the assets. 

Estimated useful lives of depreciable assets are as follows:

Buildings and improvements 10 – 50 years
Machinery and equipment 3 – 20 years
Furniture and fixtures 7 – 10 years
Income Taxes

Income Taxes

The Company follows the provisions of Accounting Standards Codification (“ASC”) Topic 740-10, "Accounting for Income Taxes."

Under the provisions of ASC 740-10, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred taxes and liabilities of a change in tax rates is recognized in earnings in the period that includes the enactment date.

Cash and Cash Equivalents

Cash and Cash Equivalents

Cash and cash equivalents consist of cash and money market funds. The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. 

Investment Securities

Investment Securities

The Company accounts for its investments in debt securities in accordance with ASC 320-10-25, “Accounting for Certain Investments in Debt and Equity Securities.”  Investments in debt securities at June 30, 2023 consists of municipal bonds, and treasury bills, and at June 30, 2022, consisted of municipal bonds.  The Company classifies investments in debt securities as available-for-sale. Unrealized holding gains and losses, net of related tax effect, on available-for-sale debt securities are excluded from earnings and are reported as a separate component of stockholders’ equity until realized.  Realized gains and losses for debt securities classified as available-for-sale are included in earnings and are determined using the specific identification method.  Interest income is recognized when earned.  Fair values are based on quoted market prices available as of the balance sheet date, and are therefore considered a Level 1 valuation.

Certificates of deposit held for investment with an original maturity greater than three months are carried at amortized cost and reported as short-term investments on the balance sheets. The type of certificates of deposit that the Company invests in are not considered debt securities under Financial Accounting Standards Board ("FASB") Accounting Standards Codification (“ASC”) 320, Investments - Debt Securities.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

Accounting Standards Codification (“ASC”) 820 establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.  The standard describes three levels of inputs that may be used to measure fair value:

Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.
Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
  Level 3: Significant unobservable inputs that reflect a reporting entity’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The carrying amounts of financial instruments, including cash and cash equivalents, short term investment securities, accounts receivable, accounts payable and accrued expenses, approximated fair value as of June 30, 2023 and 2022 because of the immediate or short-term maturity of these financial instruments. 

Accounts Receivable and Allowance for Doubtful Accounts

Accounts Receivable and Allowance for Doubtful Accounts

The Company extends credit to its customers in the normal course of business and collateral is generally not required for trade receivables.  Exposure to credit risk is controlled through the use of credit approvals, credit limits, and monitoring procedures.  Accounts receivable are reported net of an allowance for doubtful accounts.  The Company estimates the allowance based on its analysis of specific balances. Interest is not charged on past due balances.  Based on these factors, there was an allowance for doubtful accounts of $3,000 at June 30, 2023 and 2022.  Changes to the allowance for doubtful accounts are charged to expense and reduced by charge-offs, net of recoveries.

Per Share Amounts

Per Share Amounts

ASC 260-10 “Earnings Per Share (EPS)” requires the Company to calculate net income per share based on basic and diluted net income per share, as defined. Basic EPS excludes dilution and is computed by dividing net income by the weighted average number of shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. The dilutive effect of outstanding options issued by the Company are reflected in diluted EPS using the treasury stock method. Under the treasury stock method, options will only have a dilutive effect when the average market price of common stock during the period exceeds the exercise price of the options.

Comprehensive Income

Comprehensive Income

Comprehensive income consists of net income and other comprehensive income (loss).  Other comprehensive income for fiscal years ended June 30, 2023 and 2022 consists of unrealized holding gains (losses) on available-for-sale debt securities. 

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Recently Issued Accounting Standards

Recently Adopted Accounting Standards

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” ASU 2019-12 amends ASC 740 to simplify the accounting for income taxes by removing certain exceptions for investments, intraperiod allocations and interim calculations, and adding guidance to reduce complexity in the accounting standard under the FASB’s simplification initiative. ASU 2019-12 is effective for public entities for fiscal years beginning after December 15, 2020. Upon adoption, the amendments in ASU 2019-12 should be applied on a prospective basis to all periods presented. The Company adopted the new guidance under ASU 2019-12 in the first quarter of fiscal year 2022 and removed the exception for intraperiod allocations from its interim period tax provision calculation, accordingly. The removal of the exception for intraperiod allocations did not have a material impact on the Company.

Recent Accounting Pronouncements Not Yet Adopted

Recent Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”, which requires a financial asset measured at amortized cost basis to be presented at the net amount expected to be collected, with further clarifications made more recently. For trade receivables, loans and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities are required to be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for public entities for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Upon adoption, the amendments in ASU 2016-13 should be applied on a prospective basis to all periods presented relating to available-for-sale debt securities. For all other financial instruments the Company upon adoption will apply the amendments on a modified-retrospective approach. The Company is expected to adopt the new guidance under ASU 2016-13 in the first quarter of fiscal year 2024 and is currently evaluating the impact of the adoption on its financial statements. The adoption of this standard is not expected to have a material impact on the Company’s financial statements.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

Long-lived assets, including property, plant, and equipment, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset.  If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.  There were no impairments of long-lived assets in fiscal years 2023 and 2022.  Assets to be disposed of are separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell, and no longer depreciated.  The assets and liabilities of a disposed group classified as held for sale are presented separately in the appropriate asset and liability sections of the balance sheet, if applicable.

Concentrations of Risk

Concentrations of Risk

The market for our defense electronics products is largely dependent on the availability of new contracts from the United States and foreign governments to prime contractors to which we provide components.  Any decline in expenditures by the United States or foreign governments may have an adverse effect on our financial performance. 

Generally, U.S. Government contracts are subject to procurement laws and regulations.  Some of the Company’s contracts are governed by the Federal Acquisition Regulation (FAR), which lays out uniform policies and procedures for acquiring goods and services by the U.S. Government, and agency-specific acquisition regulations that implement or supplement the FAR.  For example, the Department of Defense implements the FAR through the Defense Federal Acquisition Regulation (DFAR).

The FAR also contains guidelines and regulations for managing a contract after award, including conditions under which contracts may be terminated, in whole or in part, at the government’s convenience or for default.  If a contract is terminated for the convenience of the government, a contractor is entitled to receive payments for its allowable costs and, in general, the proportionate share of fees or earnings for the work done.  If a contract is terminated for default, the government generally pays for only the work it has accepted.  These regulations also subject the Company to financial audits and other reviews by the government of its costs, performance, accounting and general business practices relating to its contracts, which may result in adjustment of the Company’s contract-related costs and fees.

v3.23.3
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies [Abstract]  
Schedule of the Estimated Useful Lives of Depreciable Assets Estimated useful lives of depreciable assets are as follows:
Buildings and improvements 10 – 50 years
Machinery and equipment 3 – 20 years
Furniture and fixtures 7 – 10 years
v3.23.3
Investment Securities (Tables)
12 Months Ended
Jun. 30, 2023
Investment Securities [Abstract]  
Schedule of Available-for-Sale Securities The Company classifies investment securities as available-for-sale which have been determined to be level 1 assets.  The cost, gross unrealized gains, gross unrealized losses and fair value debt securities by major security type at June 30, 2023 and June 30, 2022 are as follows:
       Gross   Gross     
   Amortized   Unrealized   Unrealized   Fair 
   Cost   Gains   Losses   Value 
June 30, 2023                
Certificates of deposit  $11,280,000   $
   $
   $11,280,000 
Municipal bonds  $260,475   $165   $(7,843)  $252,797 
U.S. Treasury Bills  $430,952   $1,225   $(301)  $431,876 
Total investment securities  $11,971,427   $1,390   $(8,144)  $11,964,673 

 

       Gross   Gross     
   Amortized   Unrealized   Unrealized   Fair 
   Cost   Gains   Losses   Value 
June 30, 2022                
Certificates of deposit  $3,639,000   $
   $
   $3,639,000 
Municipal bonds  $72,225   $
   $(2,446)  $69,779 
Total investment securities  $3,711,225   $
   $(2,446)  $3,708,779 
Schedule of Contractual Maturities As of June 30, 2023 and June 30, 2022, the remaining contractual maturities of available-for-sale debt securities were as follows:
   Years to Maturity     
   Less than   One to     
   One Year   Five Years   Total 
June 30, 2023               
Available-for-sale  $11,711,876   $252,797   $11,964,673 
                
June 30, 2022               
Available-for-sale  $3,639,000   $69,779   $3,708,779 
v3.23.3
Contracts in Process (Tables)
12 Months Ended
Jun. 30, 2023
Contracts in Process [Abstract]  
Schedule of Contracts in Process Contracts in process at June 30, 2023 and 2022 are as follows:
   2023   2022 
Unrecognized gross contract value  $83,577,153   $76,782,028 
Costs related to contracts in process  $17,318,579   $16,207,419 
v3.23.3
Property, Plant and Equipment (Tables)
12 Months Ended
Jun. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment Property, plant and equipment at June 30, 2023 and 2022 is as follows:
   2023   2022 
Land  $45,000   $45,000 
Building and improvements   4,811,179    4,450,399 
Machinery and equipment   11,402,679    11,287,648 
Furniture and fixtures   164,200    164,200 
    16,423,058    15,947,247 
Accumulated depreciation   (13,597,969)   (13,149,254)
Property, plant and equipment, net  $2,825,089   $2,797,993 

 

v3.23.3
Provision for Income Taxes (Tables)
12 Months Ended
Jun. 30, 2023
Provision for Income Taxes [Abstract]  
Schedule of Components of the Provision for Income Taxes A summary of the components of the provision for income taxes for the years ended June 30, 2023 and 2022 is as follows:
   2023   2022 
Current tax expense - federal  $1,059,743   $313,705 
Current tax expense - state   9,595    4,978 
Deferred tax (benefit) expense   (40,002)   9,271 
Provision for income taxes  $1,029,336   $327,954 
Schedule of Effective Income Tax Rates The combined U.S. federal and state effective income tax rates
   2023   2022 
U.S. federal statutory income tax rate   21.0%   21.0%
Increase (reduction) in rate resulting from:          
State franchise tax, net of federal income tax benefit   0.2    0.3 
ESOP cost versus Fair Market Value   (0.2)   (1.3)
Dividend on allocated ESOP shares   
    (3.1)
Stock-based compensation   1.0    4.0 
Rate Differential on Net Operating Loss Carryback   
    (0.1)
Other   (0.1)   (0.2)
Effective tax rate   21.9%   20.6%
Schedule of Deferred Tax Assets and Liabilities deferred tax assets and deferred tax liabilities as of June 30, 2023 and 2022 are presented as follows:
   2023   2022 
Deferred tax assets:          
Accrued expenses  $273,059   $204,774 
ESOP   24,407    14,237 
Stock-based compensation   36,552    33,719 
Total deferred tax assets  $334,018   $252,730 
           
Deferred tax liability:          
Property, plant and equipment - principally due to differences in depreciation methods  $337,501   $374,566 
Inventory - effect of uniform capitalization   99,215    19,276 
Prepaid expenses   35,129    36,716 
Total deferred tax liability  $471,845   $430,558 
           
Net deferred tax liability  $(137,827)  $(177,828)
v3.23.3
Employee Stock Ownership Plan (Tables)
12 Months Ended
Jun. 30, 2023
Employee Stock Ownership Plan [Abstract]  
Schedule of ESOP Shares The ESOP shares as of June 30, 2023 and 2022 were as follows:
   2023   2022 
Allocated shares   484,958    496,091 
Unreleased shares   233,645    256,293 
Total shares held by the ESOP   718,603    752,384 
Fair value of unreleased shares  $3,913,554   $3,649,612 
v3.23.3
Stock-Based Compensation (Tables)
12 Months Ended
Jun. 30, 2023
Stock Based Compensation [Abstract]  
Schedule of Weighted Average Assumptions for Option Awards The table below outlines the weighted average assumptions that the Company used to calculate the fair value of each option award for the year ended June 30, 2023 and 2022.
   2023  2022
Dividend yield  0.03% 
Expected stock price volatility  27.20%  25.60%
Risk-free interest rate  2.71%  0.99%
Expected option life (in years)  5.4yrs  5.4yrs
Weighted average fair value per share of options granted during the period  $4.18  $3.74
Schedule of Stock Option Activity The following table summarizes stock option activity during the twelve months ended June 30, 2023:
   Employee Stock Options Plan
         Weighted   
   Number of  Weighted  Average   
   Shares  Average  Remaining  Aggregate
   Subject  Exercise  Contractual  Intrinsic
   to Option  Price  Term  Value
Balance at July 1, 2022   246,273   $20.89    6.73      
Granted   74,200   $13.81    9.12      
Exercised   
    
    
      
Forfeited or expired   (24,142)  $20.46    
      
Outstanding at June 30, 2023   296,331   $19.15    6.49   $338,243 
Vested or expected to vest at June 30, 2023   283,745   $19.40    6.38   $298,723 
Exercisable at June 30, 2023   163,731   $23.13    4.74   $0 
Schedule of Changes in Non-Vested Stock Options The following table summarizes changes in non-vested stock options during the twelve months ended June 30, 2023:
       Weighted 
   Number of   Average 
   Shares   Grant Date 
   Subject   Fair Value 
   to Option   (per Option) 
Non-Vested at July 1, 2022   104,175   $2.92 
Granted   74,200    4.18 
Vested   (34,075)   1.59 
Forfeited or expired   (11,700)   2.75 
Non-Vested at June 30, 2023   132,600   $3.98 
v3.23.3
Stockholders' Equity (Tables)
12 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Schedule of Reserved Common Shares for Future Issuance The Company has reserved common shares for future issuance as follows as of June 30, 2023:
Stock options outstanding   296,331 
Stock options available for issuance   154,169 
Number of common shares reserved   450,500 
Schedule of Reconciliation of the Numerators and Denominators of the Basic and Diluted Earnings Per Share Computations The following table sets forth the reconciliation of the numerators and denominators of the basic and diluted earnings per share computations for continuing operations for the years ended June 30:
   2023   2022 
Numerator:        
Net income  $3,677,131   $1,265,127 
           
Denominator:          
           
Basic EPS:          
Common shares outstanding, beginning of period   2,702,633    2,702,633 
Common shares issued to ESOP during the period   
    
 
Unearned ESOP shares   (256,293)   (279,429)
Weighted average common shares issued during the period   
    
 
Weighted average common shares purchased during the period   
    
 
Weighted average ESOP shares earned during the period   8,516    8,700 
Denominator for basic earnings per common shares – Weighted average common shares   2,454,856    2,431,904 
Diluted EPS:          
Common shares outstanding, beginning of period   2,702,633    2,702,633 
Common shares issued to ESOP during the period   
    
 
Unearned ESOP shares   (256,293)   (279,429)
Weighted average common shares issued during the period   
    
 
Weighted average common shares purchased during the period   
    
 
Weighted average ESOP shares earned during the period   8,516    8,700 
Weighted average dilutive effect of stock options   16,160    
 
Denominator for diluted earnings per common shares – Weighted average common shares   2,471,016    2,431,904 

 

v3.23.3
Quarterly Financial Information (Unaudited) (Tables)
12 Months Ended
Jun. 30, 2023
Quarterly Financial Information (Unaudited) [Abstract]  
Schedule of Quarterly Financial Information
   First   Second   Third   Fourth 
2023  Quarter   Quarter   Quarter   Quarter 
Net sales  $8,635,795   $8,804,109   $9,809,616   $8,342,803 
Gross profit   1,812,142    2,260,722    1,973,429    2,004,245 
Net income   768,266    1,146,042    867,288    895,535 
Net income per share -                    
Basic   0.31    0.47    0.35    0.37 
Diluted   0.31    0.47    0.35    0.36 
                     
2022                    
Net sales  $7,545,432   $7,458,050   $8,620,049   $8,481,243 
Gross profit   1,353,098    1,206,817    1,734,880    1,177,363 
Net income   306,061    21,201    661,359    276,506 
Net income per share -                    
Basic   0.13    0.01    0.27    0.11 
Diluted   0.13    0.01    0.27    0.11 
v3.23.3
Summary of Significant Accounting Policies (Details) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Summary of Significant Accounting Policies [Abstract]    
Doubtful accounts $ 3,000 $ 3,000
v3.23.3
Summary of Significant Accounting Policies (Details) - Schedule of the Estimated Useful Lives of Depreciable Assets
Jun. 30, 2023
Buildings and improvements [Member] | Minimum [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the Estimated Useful Lives of Depreciable Assets [Line Items]  
Estimated useful lives of depreciable assets 10 years
Buildings and improvements [Member] | Maximum [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the Estimated Useful Lives of Depreciable Assets [Line Items]  
Estimated useful lives of depreciable assets 50 years
Machinery and equipment [Member] | Minimum [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the Estimated Useful Lives of Depreciable Assets [Line Items]  
Estimated useful lives of depreciable assets 3 years
Machinery and equipment [Member] | Maximum [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the Estimated Useful Lives of Depreciable Assets [Line Items]  
Estimated useful lives of depreciable assets 20 years
Furniture and fixtures [Member] | Minimum [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the Estimated Useful Lives of Depreciable Assets [Line Items]  
Estimated useful lives of depreciable assets 7 years
Furniture and fixtures [Member] | Maximum [Member]  
Summary of Significant Accounting Policies (Details) - Schedule of the Estimated Useful Lives of Depreciable Assets [Line Items]  
Estimated useful lives of depreciable assets 10 years
v3.23.3
Revenue (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Revenue (Details) [Line Items]    
Revenue $ 35,592,323 $ 32,104,774
Contract liabilities 2,018,642  
ASC 606 [Member]    
Revenue (Details) [Line Items]    
Contract liabilities 8,081,838 3,384,474
Units Delivered [Member] | ASC 606 [Member]    
Revenue (Details) [Line Items]    
Revenue 27,770,365 26,931,949
Milestones Achieved [Member] | ASC 606 [Member]    
Revenue (Details) [Line Items]    
Revenue 7,821,958 $ 5,172,825
Order or Production Backlog [Member] | ASC 606 [Member]    
Revenue (Details) [Line Items]    
Intangible assets $ 83,600,000  
Backlog amount to be recognized, 2024 47.00%  
Backlog amount to be recognized, 2025 38.00%  
Backlog amount to be recognized, 2026 11.00%  
Backlog amount to be recognized 4.00%  
v3.23.3
Investment Securities (Details) - Schedule of Available-for-Sale Securities - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Schedule of Available-for-Sale Securities [Abstract]    
Amortized cost $ 11,971,427 $ 3,711,225
Gross Unrealized Gains 1,390
Gross Unrealized Losses (8,144) (2,446)
Fair Value 11,964,673 3,708,779
Certificates of Deposit [Member]    
Schedule of Available-for-Sale Securities [Abstract]    
Amortized cost 11,280,000 3,639,000
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value 11,280,000 3,639,000
Municipal Bonds [Member]    
Schedule of Available-for-Sale Securities [Abstract]    
Amortized cost 260,475 72,225
Gross Unrealized Gains 165
Gross Unrealized Losses (7,843) (2,446)
Fair Value 252,797 $ 69,779
US Treasury Bill Securities [Member]    
Schedule of Available-for-Sale Securities [Abstract]    
Amortized cost 430,952  
Gross Unrealized Gains 1,225  
Gross Unrealized Losses (301)  
Fair Value $ 431,876  
v3.23.3
Investment Securities (Details) - Schedule of Contractual Maturities - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Schedule of Contractual Maturities [Abstract]    
Less than One Year $ 11,711,876 $ 3,639,000
One to Five Years 252,797 69,779
Fair Value $ 11,964,673 $ 3,708,779
v3.23.3
Contracts in Process (Details) - Schedule of Contracts in Process - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Schedule Of Contracts In Process Abstract    
Unrecognized gross contract value $ 83,577,153 $ 76,782,028
Costs related to contracts in process $ 17,318,579 $ 16,207,419
v3.23.3
Property, Plant and Equipment (Details) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Sep. 19, 2023
Dec. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment (Details) [Line Items]        
Depreciation expense     $ 484,920 $ 494,635
Funding amount   $ 7,400,000    
Property, Plant and equipment, Net     2,825,089 2,797,993
Revenue recognition, Milestone method, Revenues recognized $ 969,000      
Building Improvements [Member]        
Property, Plant and Equipment (Details) [Line Items]        
Property, Plant and equipment, Net     $ 308,001 $ 58,296
v3.23.3
Property, Plant and Equipment (Details) - Schedule of Property, Plant and Equipment - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 16,423,058 $ 15,947,247
Accumulated depreciation (13,597,969) (13,149,254)
Property, plant and equipment, net 2,825,089 2,797,993
Land [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 45,000 45,000
Building and improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 4,811,179 4,450,399
Property, plant and equipment, net 308,001 58,296
Machinery and equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross 11,402,679 11,287,648
Furniture and fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, gross $ 164,200 $ 164,200
v3.23.3
Pension Expense (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Pension Expense [Abstract]    
Defined benefit contributions and expenses $ 102,612 $ 110,378
Expenses contributions $ 72,350 $ 73,771
Percentage of employer contribution 10.00% 10.00%
Employee contribution $ 53,768 $ 53,836
v3.23.3
Provision for Income Taxes (Details) - Schedule of Components of the Provision for Income Taxes - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Schedule of Components of the Provision for Income Taxes [Abstract]    
Current tax expense - federal $ 1,059,743 $ 313,705
Current tax expense - state 9,595 4,978
Deferred tax (benefit) expense (40,002) 9,271
Provision for income taxes $ 1,029,336 $ 327,954
v3.23.3
Provision for Income Taxes (Details) - Schedule of Effective Income Tax Rates
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Schedule of Effective Income Tax Rates [Abstract]    
U.S. federal statutory income tax rate 21.00% 21.00%
Increase (reduction) in rate resulting from:    
State franchise tax, net of federal income tax benefit 0.20% 0.30%
ESOP cost versus Fair Market Value (0.20%) (1.30%)
Dividend on allocated ESOP shares (3.10%)
Stock-based compensation 1.00% 4.00%
Rate Differential on Net Operating Loss Carryback (0.10%)
Other (0.10%) (0.20%)
Effective tax rate 21.90% 20.60%
v3.23.3
Provision for Income Taxes (Details) - Schedule of Deferred Tax Assets and Liabilities - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Deferred tax assets:    
Accrued expenses $ 273,059 $ 204,774
ESOP 24,407 14,237
Stock-based compensation 36,552 33,719
Total deferred tax assets 334,018 252,730
Deferred tax liability:    
Property, plant and equipment - principally due to differences in depreciation methods 337,501 374,566
Inventory - effect of uniform capitalization 99,215 19,276
Prepaid expenses 35,129 36,716
Total deferred tax liability 471,845 430,558
Net deferred tax liability $ (137,827) $ (177,828)
v3.23.3
Significant Customers (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Geographic Concentration Risk [Member] | Revenue Benchmark [Member]    
Significant Customers (Details) [Line Items]    
Concentration risk percentage 81.00% 57.00%
Geographic Concentration Risk [Member] | Accounts Receivable [Member]    
Significant Customers (Details) [Line Items]    
Concentration risk percentage 81.00% 74.00%
Foreign Customers [Member] | Revenue Benchmark [Member]    
Significant Customers (Details) [Line Items]    
Sales (in Dollars) $ 549,510 $ 1,644,000
v3.23.3
Employee Stock Ownership Plan (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Employee Stock Ownership Plan (Details) [Line Items]    
Employee stock ownership plan (ESOP) The Company sponsors a leveraged employee stock ownership plan (the "ESOP") that covers all nonunion employees who work 1,000 or more hours per year and are employed on June 30.  
ESOP compensation expense $ 365,646 $ 325,067
Employee Stock Ownership Plan [Member]    
Employee Stock Ownership Plan (Details) [Line Items]    
Interest rate on loan 3.00%  
ESOP compensation expense $ 365,646 $ 325,067
Shares distributed 33,780 14,265
v3.23.3
Employee Stock Ownership Plan (Details) - Schedule of ESOP Shares - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Schedule of ESOP Shares [Abstract]    
Allocated shares 484,958 496,091
Unreleased shares 233,645 256,293
Total shares held by the ESOP 718,603 752,384
Fair value of unreleased shares (in Dollars) $ 3,913,554 $ 3,649,612
v3.23.3
Stock-Based Compensation (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Stock-Based Compensation (Details) [Line Items]    
Stock based compensation expense $ 227,132 $ 176,696
Deferred tax benefit related to stock based compensation 4,501 $ 6,150
Unrecognized compensation costs 155,154  
Period in which compensation cost will be recognized   2 years
Deferred tax benefit related to unrecognized compensation costs $ 5,541  
Shares remain available for grant (in Shares) 154,169  
Shares cancelled (in Shares) 24,142  
Aggregate intrinsic value of options exercised $ 0 $ 0
Non employee directors [Member] | Maximum [Member] | 2017 Plan [Member]    
Stock-Based Compensation (Details) [Line Items]    
Authorized shares under plan (in Shares) 133,000  
Vesting period (in Shares) 13,300  
Percentage of total number of shares subject to options or awards, single fiscal year 33 1/3%  
Individual Employee [Member] | Maximum [Member] | 2017 Plan [Member]    
Stock-Based Compensation (Details) [Line Items]    
Vesting period (in Shares) 15,000  
Non-qualified stock options [Member]    
Stock-Based Compensation (Details) [Line Items]    
Stock based compensation expense $ 21,432 $ 29,287
Unrecognized compensation costs $ 26,388  
Common stock per share (in Dollars per share) $ 0.2  
Incentive Stock Options [Member]    
Stock-Based Compensation (Details) [Line Items]    
Unrecognized compensation costs $ 128,766  
Incentive Stock Options [Member] | 2017 Plan [Member]    
Stock-Based Compensation (Details) [Line Items]    
Outstanding shares (in Shares) 245,831  
Shares cancelled (in Shares) 136,273  
Share-Based Payment Arrangement, Option [Member] | 2017 Plan [Member]    
Stock-Based Compensation (Details) [Line Items]    
Authorized shares under plan (in Shares) 400,000  
Vesting period 2 years  
Shares remain available for grant (in Shares) 382,104  
Restricted Stock Plan [Member] | 2007 Plan [Member]    
Stock-Based Compensation (Details) [Line Items]    
Outstanding shares (in Shares) 50,500  
v3.23.3
Stock-Based Compensation (Details) - Schedule of Weighted Average Assumptions for Option Awards - $ / shares
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Schedule of Fair Value Assumptions [Abstract]    
Dividend yield 0.03%
Expected stock price volatility 27.20% 25.60%
Risk-free interest rate 2.71% 0.99%
Expected option life (in years) 5 years 4 months 24 days 5 years 4 months 24 days
Weighted average fair value per share of options granted during the period (in Dollars per share) $ 4.18 $ 3.74
v3.23.3
Stock-Based Compensation (Details) - Schedule of Stock Option Activity
12 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Schedule of Stock Option Activity [Abstract]  
Number of Shares Subject to Option, Beginning | shares 246,273
Weighted Average Exercise Price, Beginning | $ / shares $ 20.89
Weighted Average Remaining Contractual Term, Beginning 6 years 8 months 23 days
Number of Shares Subject to Option, Granted | shares 74,200
Weighted Average Exercise Price, Granted | $ / shares $ 13.81
Weighted Average Remaining Contractual Term, Granted 9 years 1 month 13 days
Number of Shares Subject to Option, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Weighted Average Remaining Contractual Term, Exercised
Number of Shares Subject to Option, Forfeited or expired | shares (24,142)
Weighted Average Exercise Price, Forfeited or expired | $ / shares $ 20.46
Weighted Average Remaining Contractual Term, Forfeited or expired
Number of Shares Subject to Option, Ending | shares 296,331
Weighted Average Exercise Price, Ending | $ / shares $ 19.15
Weighted Average Remaining Contractual Term, Ending 6 years 5 months 26 days
Aggregate Intrinsic Value, Ending | $ $ 338,243
Number of Shares Subject to Option, Vested or expected to vest | shares 283,745
Weighted Average Exercise Price, Vested or expected to vest | $ / shares $ 19.4
Weighted Average Remaining Contractual Term, Vested or expected to vest 6 years 4 months 17 days
Aggregate Intrinsic Value, Vested or expected to vest | $ $ 298,723
Number of Shares Subject to Option, Exercisable | shares 163,731
Weighted Average Exercise Price, Exercisable | $ / shares $ 23.13
Weighted Average Remaining Contractual Term, Exercisable 4 years 8 months 26 days
Aggregate Intrinsic Value, Exercisable | $ $ 0
v3.23.3
Stock-Based Compensation (Details) - Schedule of Changes in Non-Vested Stock Options
12 Months Ended
Jun. 30, 2023
$ / shares
shares
Schedule of Changes in Non-Vested Stock Options [Abstract]  
Weighted Number of Shares Subject to Option, Non-vested Beginning | shares 104,175
Average Grant Date Fair Value (per Option), Non-vested Beginning | $ / shares $ 2.92
Weighted Number of Shares Subject to Option, Granted | shares 74,200
Average Grant Date Fair Value (per Option), Granted | $ / shares $ 4.18
Weighted Number of Shares Subject to Option, Vested | shares (34,075)
Average Grant Date Fair Value (per Option), Vested | $ / shares $ 1.59
Weighted Number of Shares Subject to Option, Forfeited or expired | shares (11,700)
Average Grant Date Fair Value (per Option), Forfeited or expired | $ / shares $ 2.75
Weighted Number of Shares Subject to Option, Non-vested Ending | shares 132,600
Average Grant Date Fair Value (per Option), Non-vested Ending | $ / shares $ 3.98
v3.23.3
Concentration of Credit Risk (Details) - Trade Accounts Receivable [Member] - Revenue Benchmark [Member]
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Concentration of Credit Risk (Details) [Line Items]    
Trade accounts receivable balance 81.00% 74.00%
Represented customers 5 4
v3.23.3
Commitments and Contingencies (Details) - USD ($)
Jun. 30, 2023
Jun. 30, 2022
Standby Letters of Credit [Member]    
Commitments and Contingencies (Details) [Line Items]    
Contingent liabilities $ 0 $ 0
v3.23.3
Stockholders' Equity (Details) - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Stockholders' Equity Note [Abstract]    
Purchase shares of common stock 130,656 246,273
Cash dividends on common stock (in Dollars per share) $ 0.2  
Cash dividends (in Dollars)  
v3.23.3
Stockholders' Equity (Details) - Schedule of Reserved Common Shares for Future Issuance - shares
Jun. 30, 2023
Jun. 30, 2022
Stockholders' Equity (Details) - Schedule of Reserved Common Shares for Future Issuance [Line Items]    
Stock options outstanding 296,331 246,273
Stock options available for issuance 154,169  
Number of common shares reserved 450,500  
v3.23.3
Stockholders' Equity (Details) - Schedule of Reconciliation of the Numerators and Denominators of the Basic and Diluted Earnings Per Share Computations - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Stockholders' Equity (Details) - Schedule of Reconciliation of the Numerators and Denominators of the Basic and Diluted Earnings Per Share Computations [Line Items]    
Net income (loss) (in Dollars) $ 3,677,131 $ 1,265,127
Basic EPS:    
Common shares outstanding, beginning of period 2,702,633 2,702,633
Common shares issued to ESOP during the period
Unearned ESOP shares (256,293) (279,429)
Weighted average common shares issued during the period
Weighted average common shares purchased during the period
Weighted average ESOP shares earned during the period 8,516 8,700
Denominator for basic earnings per common shares – Weighted average common shares 2,454,856 2,431,904
Diluted EPS:    
Common shares outstanding, beginning of period 2,702,633 2,702,633
Common shares issued to ESOP during the period
Unearned ESOP shares (256,293) (279,429)
Weighted average common shares issued during the period
Weighted average common shares purchased during the period
Weighted average ESOP shares earned during the period 8,516 8,700
Weighted average dilutive effect of stock options 16,160
Denominator for diluted earnings per common shares – Weighted average common shares 2,471,016 2,431,904
v3.23.3
Line of Credit (Details)
12 Months Ended
Jun. 30, 2023
USD ($)
Line of Credit (Details) [Line Items]  
Maximum amount of line of credit $ 3,000,000
London Interbank Offered Rates (LIBOR) [Member]  
Line of Credit (Details) [Line Items]  
Daily floating rate 2.00%
v3.23.3
Quarterly Financial Information (Unaudited) (Details) - Schedule of Quarterly Financial Information - USD ($)
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
First Quarter [Member]    
Schedule of Quarterly Financial Information [Abstract]    
Net sales $ 8,635,795 $ 7,545,432
Gross profit 1,812,142 1,353,098
Net income $ 768,266 $ 306,061
Net income per share -    
Basic (in Dollars per share) $ 0.31 $ 0.13
Diluted (in Dollars per share) $ 0.31 $ 0.13
Second Quarter [Member]    
Schedule of Quarterly Financial Information [Abstract]    
Net sales $ 8,804,109 $ 7,458,050
Gross profit 2,260,722 1,206,817
Net income $ 1,146,042 $ 21,201
Net income per share -    
Basic (in Dollars per share) $ 0.47 $ 0.01
Diluted (in Dollars per share) $ 0.47 $ 0.01
Third Quarter [Member]    
Schedule of Quarterly Financial Information [Abstract]    
Net sales $ 9,809,616 $ 8,620,049
Gross profit 1,973,429 1,734,880
Net income $ 867,288 $ 661,359
Net income per share -    
Basic (in Dollars per share) $ 0.35 $ 0.27
Diluted (in Dollars per share) $ 0.35 $ 0.27
Fourth Quarter [Member]    
Schedule of Quarterly Financial Information [Abstract]    
Net sales $ 8,342,803 $ 8,481,243
Gross profit 2,004,245 1,177,363
Net income $ 895,535 $ 276,506
Net income per share -    
Basic (in Dollars per share) $ 0.37 $ 0.11
Diluted (in Dollars per share) $ 0.36 $ 0.11

Espey Manufacturing and ... (AMEX:ESP)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Espey Manufacturing and ....
Espey Manufacturing and ... (AMEX:ESP)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Espey Manufacturing and ....